---
title: "Biotech reverse split, Nasdaq notice and delisting tracker"
url: "https://aibio.space/reverse-split-tracker/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "Reverse stock splits, Nasdaq and NYSE deficiency notices, regained compliance, delistings and new listings at public biotech companies, newest first."
---

Tracker

# Reverse split, Nasdaq notice and delisting tracker

Reverse stock splits, Nasdaq and NYSE deficiency notices, regained compliance, delistings and new listings at public biotech companies, newest first.

Updated October 31, 2026. 538 entries. [Download as CSV](https://aibio.space/reverse-split-tracker.csv). Free to cite with a link to this page. [All trackers](https://aibio.space/trackers/).

- **137**Reverse split
- **130**Deficiency notice
- **120**Listing change
- **81**Delisting
- **67**Regained compliance
- **3**New listing

| Date | Company | Type | What happened |
|---|---|---|---|
| 2026-10-29 | Propanc Biopharma [PPCB](https://aibio.space/companies/propanc-biopharma/) | Reverse split | [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/) |
| 2026-10-29 | Reviva Pharmaceuticals Holdings [RVPH](https://aibio.space/companies/reviva-pharmaceuticals/) | Reverse split | [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/) |
| 2026-10-28 | Glucotrack [GCTK](https://aibio.space/companies/glucotrack/) | Delisting | [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/) |
| 2026-10-28 | Milestone Pharmaceuticals [MIST](https://aibio.space/companies/milestone-pharmaceuticals/) | Listing change | [Milestone Pharmaceuticals falls below Nasdaq's $1.00 minimum bid rule](https://aibio.space/news/milestone-pharmaceuticals-falls-below-nasdaqs-1-00-minimum-bid-rule/) |
| 2026-10-28 | OSR Health [OSRH](https://aibio.space/companies/osr-health/) | Delisting | [Nasdaq panel delists OSR Health over $1.00 bid price rule](https://aibio.space/news/nasdaq-panel-delists-osr-health-1-00-bid-price-rule/) |
| 2026-10-27 | aTyr Pharma [ATYR](https://aibio.space/companies/atyr-pharma/) | Reverse split | [aTyr Pharma sets 1-for-40 reverse split, shares trade adjusted from October 29](https://aibio.space/news/atyr-pharma-sets-1-40-reverse-split-shares-trade-adjusted-october-29/) |
| 2026-10-27 | CDT Equity [CDT](https://aibio.space/companies/cdt-equity/) | Reverse split | [CDT Equity seeks votes on reverse splits up to 1-for-1,000 and Astor note shares](https://aibio.space/news/cdt-equity-seeks-votes-reverse-splits-up-1-1-000-astor-note-shares/) |
| 2026-10-27 | Enlivex [ENLV](https://aibio.space/companies/enlivex/) | Reverse split | [Enlivex gets Nasdaq delisting notice, plans appeal and 1-for-16 reverse split](https://aibio.space/news/enlivex-gets-nasdaq-delisting-notice-plans-appeal-1-16-reverse-split/) |
| 2026-10-27 | GeoVax Labs [GOVX](https://aibio.space/companies/geovax-labs/) | Listing change | [GeoVax signs $1,000,000 credit line as five directors make way for lender nominees](https://aibio.space/news/geovax-signs-1-000-000-credit-line-five-directors-make-way-lender/) |
| 2026-10-27 | GeoVax Labs [GOVX](https://aibio.space/companies/geovax-labs/) | Reverse split | [GeoVax stockholders approve reverse split of up to 1-for-25 and warrant share issuance](https://aibio.space/news/geovax-stockholders-approve-reverse-split-up-1-25-warrant-share/) |
| 2026-10-27 | Pulmatrix [PULM](https://aibio.space/companies/pulmatrix/) | Reverse split | [Pulmatrix stockholders approve Eos SENOLYTIX merger and a reverse split](https://aibio.space/news/pulmatrix-stockholders-approve-eos-senolytix-merger-reverse-split/) |
| 2026-10-26 | AEON Biopharma [AEON](https://aibio.space/companies/aeon-biopharma/) | Reverse split | [AEON Biopharma seeks approval for a reverse split of up to 1-for-100](https://aibio.space/news/aeon-biopharma-seeks-approval-reverse-split-up-1-100/) |
| 2026-10-26 | Oncopeptides AB [ONCO](https://aibio.space/companies/oncopeptides/) | Reverse split | [Onconetix sets a 1-for-10 reverse stock split for November 6](https://aibio.space/news/onconetix-sets-1-10-reverse-stock-split-november-6/) |
| 2026-10-26 | Skye Bioscience [SKYE](https://aibio.space/companies/skye-bioscience/) | Reverse split | [Skye Bioscience files preliminary proxy for its Redx Pharma acquisition](https://aibio.space/news/skye-bioscience-files-preliminary-proxy-redx-pharma-acquisition/) |
| 2026-10-26 | Silexion Therapeutics [SLXN](https://aibio.space/companies/silexion-therapeutics/) | Reverse split | [Silexion shareholders back a 1-for-24 reverse split and more authorized shares](https://aibio.space/news/silexion-shareholders-back-1-24-reverse-split-more-authorized-shares/) |
| 2026-10-26 | TScan Therapeutics [TCRX](https://aibio.space/companies/tscan-therapeutics/) | Reverse split | [TScan Therapeutics asks stockholders to approve a reverse split of up to one-for-fifty](https://aibio.space/news/tscan-therapeutics-asks-stockholders-approve-reverse-split-up-one/) |
| 2026-10-23 | Akebia Therapeutics [AKBA](https://aibio.space/companies/akebia-therapeutics/) | Reverse split | [Akebia Therapeutics gets Nasdaq bid price notice, has until April 19, 2027](https://aibio.space/news/akebia-therapeutics-gets-nasdaq-bid-price-notice-has-until-april-19/) |
| 2026-10-23 | Citius Oncology, Citius Pharmaceuticals [CTOR](https://aibio.space/companies/citius-oncology/)[CTXR](https://aibio.space/companies/citius-pharmaceuticals/) | Listing change | [Citius Oncology gets Nasdaq extension to April 19, 2027 on bid price](https://aibio.space/news/citius-oncology-gets-nasdaq-extension-april-19-2027-bid-price/) |
| 2026-10-23 | Lunai Bioworks [LNAI](https://aibio.space/companies/lunai-bioworks/) | Delisting | [Lunai Bioworks gets Nasdaq delisting notice and plans to leave the exchange](https://aibio.space/news/lunai-bioworks-gets-nasdaq-delisting-notice-plans-leave-exchange/) |
| 2026-10-23 | Medicus Pharma [MDCX](https://aibio.space/companies/medicus-pharma/) | Regained compliance | [Medicus Pharma regains Nasdaq $1.00 bid price compliance days after delisting letter](https://aibio.space/news/medicus-pharma-regains-nasdaq-1-00-bid-price-compliance-days-after/) |
| 2026-10-22 | Nuwellis [NUWE](https://aibio.space/companies/nuwellis/) | Reverse split | [Nuwellis sets one-for-nine reverse stock split effective October 26](https://aibio.space/news/nuwellis-sets-one-nine-reverse-stock-split-effective-october-26/) |
| 2026-10-22 | Azitra [AZTR](https://aibio.space/companies/azitra/) | Reverse split | [Azitra to carry out 1-for-10 reverse stock split on October 26](https://aibio.space/news/azitra-carry-out-1-10-reverse-stock-split-october-26/) |
| 2026-10-22 | Enlivex [ENLV](https://aibio.space/companies/enlivex/) | Listing change | [Enlivex announces 1-for-16 reverse share split effective October 27, 2026](https://aibio.space/news/enlivex-announces-1-16-reverse-share-split-effective-october-27-2026/) |
| 2026-10-21 | Alaunos Therapeutics [TCRT](https://aibio.space/companies/alaunos-therapeutics/) | Listing change | [Alaunos Therapeutics says $350.0 million financing restores Nasdaq equity compliance](https://aibio.space/news/alaunos-therapeutics-says-350-0-million-financing-restores-nasdaq/) |
| 2026-10-19 | Silexion Therapeutics [SLXN](https://aibio.space/companies/silexion-therapeutics/) | Reverse split | [Silexion adjourns vote on 500 million new shares and reverse split to October 26](https://aibio.space/news/silexion-adjourns-vote-500-million-new-shares-reverse-split-october-26/) |
| 2026-10-15 | Sangamo Therapeutics [SGMOQ](https://aibio.space/companies/sangamo-therapeutics/) | Delisting | [Sangamo's Nasdaq delisting becomes final as Chapter 11 case continues](https://aibio.space/news/sangamos-nasdaq-delisting-becomes-final-chapter-11-case-continues/) |
| 2026-10-15 | Mustang Bio [MBIO](https://aibio.space/companies/mustang-bio/) | Reverse split | [Mustang Bio gets a second 180-day Nasdaq grace period to fix its bid price](https://aibio.space/news/mustang-bio-gets-second-180-day-nasdaq-grace-period-fix-bid-price/) |
| 2026-10-14 | MANNATECH INC [MTEX](https://aibio.space/companies/mannatech/) | Listing change | [Mannatech says it regained Nasdaq stockholders' equity compliance](https://aibio.space/news/mannatech-says-regained-nasdaq-stockholders-equity-compliance/) |
| 2026-10-14 | Immutep [IMM](https://aibio.space/companies/immutep/) | Regained compliance | [Immutep Ltd regains Nasdaq bid price compliance after ADS ratio change](https://aibio.space/news/immutep-ltd-regains-nasdaq-bid-price-compliance-after-ads-ratio-change/) |
| 2026-10-13 | CytoMed Therapeutics [GDTC](https://aibio.space/companies/cytomed-therapeutics/) | Deficiency notice | [CytoMed Therapeutics gets Nasdaq bid price notice, has until April 5, 2027](https://aibio.space/news/cytomed-therapeutics-gets-nasdaq-bid-price-notice-has-until-april-5/) |
| 2026-10-09 | Alaunos Therapeutics [TCRT](https://aibio.space/companies/alaunos-therapeutics/) | Delisting | [Alaunos Therapeutics gets Nasdaq delisting notice under $2,500,000 stockholders' equity rule](https://aibio.space/news/alaunos-therapeutics-gets-nasdaq-delisting-notice-under-2-500-000/) |
| 2026-10-09 | Artelo Biosciences [ARTL](https://aibio.space/companies/artelo-biosciences/) | Listing change | [Artelo Biosciences flags exposure to Nasdaq's new $5,000,000 market value rule](https://aibio.space/news/artelo-biosciences-flags-exposure-nasdaqs-new-5-000-000-market-value/) |
| 2026-10-08 | Biodexa Pharmaceuticals [BDRX](https://aibio.space/companies/biodexa-pharmaceuticals/) | Listing change | [Biodexa changes ADS ratio to 400 ordinary shares, a one-for-eight reverse ADS split](https://aibio.space/news/biodexa-changes-ads-ratio-400-ordinary-shares-one-eight-reverse-ads/) |
| 2026-10-08 | Boundless Bio [BOLD](https://aibio.space/companies/boundless-bio/) | Reverse split | [Boundless Bio files S-4 for Serapha merger; partner later reports early SERP-01 data](https://aibio.space/news/boundless-bio-files-s-4-serapha-merger-partner-later-reports-early/) |
| 2026-10-07 | NEXGEL, INC. [NXGL](https://aibio.space/companies/nexgel/) | Reverse split | [NexGel sets a 1-for-20 reverse stock split effective October 12, 2026](https://aibio.space/news/nexgel-sets-1-20-reverse-stock-split-effective-october-12-2026/) |
| 2026-10-07 | Aditxt [ADTX](https://aibio.space/companies/aditxt/) | Delisting | [Nasdaq files to remove Aditxt common stock from listing](https://aibio.space/news/nasdaq-files-remove-aditxt-common-stock-listing/) |
| 2026-10-07 | Redhill Biopharma [RDHL](https://aibio.space/companies/redhill-biopharma/) | Listing change | [Redhill Biopharma gets 180 more days on Nasdaq bid price, to April 5, 2027](https://aibio.space/news/redhill-biopharma-gets-180-more-days-nasdaq-bid-price-april-5-2027/) |
| 2026-10-07 | Sangamo Therapeutics [SGMOQ](https://aibio.space/companies/sangamo-therapeutics/) | Delisting | [Nasdaq files SEC notice to remove Sangamo Therapeutics stock from listing](https://aibio.space/news/nasdaq-files-sec-notice-remove-sangamo-therapeutics-stock-listing/) |
| 2026-10-06 | VivoSim Labs, INC. [VIVS](https://aibio.space/companies/vivosim-labs/) | Reverse split | [VivoSim Labs stockholders elect two directors and approve split range](https://aibio.space/news/vivosim-labs-stockholders-elect-two-directors-approve-split-range/) |
| 2026-10-06 | Kyntra Bio [KYNB](https://aibio.space/companies/kyntra-bio/) | Delisting | [Kyntra Bio gets Nasdaq delisting determination, requests a hearing](https://aibio.space/news/kyntra-bio-gets-nasdaq-delisting-determination-requests-hearing/) |
| 2026-10-06 | Universe Pharmaceuticals [UPC](https://aibio.space/companies/universe-pharmaceuticals/) | Deficiency notice | [Universe Pharmaceuticals holders approve conditional 10-into-1 share consolidation](https://aibio.space/news/universe-pharmaceuticals-holders-approve-conditional-10-1-share/) |
| 2026-10-02 | BeyondSpring [BYSI](https://aibio.space/companies/beyondspring/) | Deficiency notice | [BeyondSpring gets Nasdaq notice after market value falls below $35 million](https://aibio.space/news/beyondspring-gets-nasdaq-notice-after-market-value-falls-below-35/) |
| 2026-10-02 | Dare Bioscience [DARE](https://aibio.space/companies/dare-bioscience/) | Reverse split | [Daré Bioscience gets Nasdaq notice for stock below $1.00](https://aibio.space/news/dare-bioscience-gets-nasdaq-notice-stock-below-1-00/) |
| 2026-10-01 | Lantern Pharma [LTRN](https://aibio.space/companies/lantern-pharma/) | Deficiency notice | [Lantern Pharma gets Nasdaq notice over $35,000,000 market value rule](https://aibio.space/news/lantern-pharma-gets-nasdaq-notice-35-000-000-market-value-rule/) |
| 2026-09-30 | Nutriband [NTRB](https://aibio.space/companies/nutriband/) | Delisting | [Nasdaq files removal notice as Nutriband public warrants expire](https://aibio.space/news/nasdaq-files-removal-notice-nutriband-public-warrants-expire/) |
| 2026-09-30 | Abpro Holdings [ABPO](https://aibio.space/companies/abpro/) | Delisting | [Nasdaq files to remove Abpro Holdings stock and warrants from listing](https://aibio.space/news/nasdaq-files-remove-abpro-holdings-stock-warrants-listing/) |
| 2026-09-30 | Clearmind Medicine [CMND](https://aibio.space/companies/clearmind-medicine/) | Listing change | [Clearmind Medicine to effect 1-for-8 reverse share split, trading from October 5, 2026](https://aibio.space/news/clearmind-medicine-effect-1-8-reverse-share-split-trading-october-5/) |
| 2026-09-30 | Evogene [EVGN](https://aibio.space/companies/evogene/) | Reverse split | [Evogene gets extra 180 days from Nasdaq to fix bid price, to March 29, 2027](https://aibio.space/news/evogene-gets-extra-180-days-nasdaq-fix-bid-price-march-29-2027/) |
| 2026-09-30 | SciSparc [SPRC](https://aibio.space/companies/scisparc/) | Listing change | [SciSparc reports $4,436 thousand in cash and $6,051 thousand loss for first half](https://aibio.space/news/scisparc-reports-4-436-thousand-cash-6-051-thousand-loss-first-half/) |
| 2026-09-30 | Tevogen [TVGN](https://aibio.space/companies/tevogen/) | Regained compliance | [Tevogen regains compliance with Nasdaq Global Market listing rules](https://aibio.space/news/tevogen-regains-compliance-nasdaq-global-market-listing-rules/) |
| 2026-09-29 | Lakewood-Amedex Biotherapeutics [LABT](https://aibio.space/companies/lakewood-amedex-biotherapeutics/) | Reverse split | [Lakewood-Amedex holders approve share increase and reverse split authority](https://aibio.space/news/lakewood-amedex-holders-approve-share-increase-reverse-split-authority/) |
| 2026-09-29 | Liminatus Pharma [LIMN](https://aibio.space/companies/liminatus-pharma/) | Reverse split | [Liminatus Pharma regains Nasdaq compliance after 1-for-50 reverse split](https://aibio.space/news/liminatus-pharma-regains-nasdaq-compliance-after-1-50-reverse-split/) |
| 2026-09-28 | Gossamer Bio [GOSS](https://aibio.space/companies/gossamer-bio/) | Reverse split | [Gossamer Bio regains Nasdaq minimum bid price compliance](https://aibio.space/news/gossamer-bio-regains-nasdaq-minimum-bid-price-compliance/) |
| 2026-09-28 | Polyrizon [PLRZ](https://aibio.space/companies/polyrizon/) | Listing change | [Polyrizon reports $8,410 thousand in cash at June 30, 2026](https://aibio.space/news/polyrizon-reports-8-410-thousand-cash-june-30-2026/) |
| 2026-09-25 | CDT Equity [CDT](https://aibio.space/companies/cdt-equity/) | Reverse split | [CDT Equity to do 1-for-25 reverse stock split on Nasdaq](https://aibio.space/news/cdt-equity-do-1-25-reverse-stock-split-nasdaq/) |
| 2026-09-25 | Calidi Biotherapeutics [CLDI](https://aibio.space/companies/calidi-biotherapeutics/) | Deficiency notice | [Calidi Biotherapeutics receives NYSE American equity deficiency notice](https://aibio.space/news/calidi-biotherapeutics-receives-nyse-american-equity-deficiency-notice/) |
| 2026-09-25 | Matinas Biopharma Holdings [MTNB](https://aibio.space/companies/matinas-biopharma/) | Reverse split | [Matinas Biopharma effects one-for-fifteen reverse stock split](https://aibio.space/news/matinas-biopharma-effects-one-fifteen-reverse-stock-split/) |
| 2026-09-25 | Silexion Therapeutics [SLXN](https://aibio.space/companies/silexion-therapeutics/) | Delisting | [Silexion adds bid-price deficiency to pending Nasdaq panel review](https://aibio.space/news/silexion-adds-bid-price-deficiency-pending-nasdaq-panel-review/) |
| 2026-09-25 | Outlook Therapeutics [OTLK](https://aibio.space/companies/outlook-therapeutics/) | Deficiency notice | [Outlook Therapeutics gets a Nasdaq bid-price notice weeks after its drug's approval](https://aibio.space/news/outlook-therapeutics-gets-nasdaq-bid-price-notice-weeks-after-drugs/) |
| 2026-09-24 | BGM Group [BGM](https://aibio.space/companies/bgm/) | Listing change | [BGM Group announces 30-for-1 share consolidation, trading from October 1, 2026](https://aibio.space/news/bgm-group-announces-30-1-share-consolidation-trading-october-1-2026/) |
| 2026-09-23 | Xenetic Biosciences [XBIO](https://aibio.space/companies/xenetic-biosciences/) | Reverse split | [Xenetic files investor presentation on proposed transaction with Santersus](https://aibio.space/news/xenetic-files-investor-presentation-proposed-transaction-santersus/) |
| 2026-09-21 | Jaguar Health [JAGX](https://aibio.space/companies/jaguar-health/) | Reverse split | [Jaguar Health completes 1-for-15 reverse split and removes old preferred series](https://aibio.space/news/jaguar-health-completes-1-15-reverse-split-removes-old-preferred/) |
| 2026-09-21 | Scinai Immunotherapeutics [SCNI](https://aibio.space/companies/scinai-immunotherapeutics/) | Regained compliance | [Scinai Immunotherapeutics regains Nasdaq bid price compliance](https://aibio.space/news/scinai-immunotherapeutics-regains-nasdaq-bid-price-compliance/) |
| 2026-09-18 | InMed Pharmaceuticals [INM](https://aibio.space/companies/inmed-pharmaceuticals/) | Deficiency notice | [InMed receives Nasdaq notice on minimum shareholders' equity](https://aibio.space/news/inmed-receives-nasdaq-notice-minimum-shareholders-equity/) |
| 2026-09-18 | Moleculin Biotech [MBRX](https://aibio.space/companies/moleculin-biotech/) | Reverse split | [Moleculin Biotech gets Nasdaq staff determination on bid price, plans hearing request](https://aibio.space/news/moleculin-biotech-gets-nasdaq-staff-determination-bid-price-plans/) |
| 2026-09-18 | BeyondSpring [BYSI](https://aibio.space/companies/beyondspring/) | Deficiency notice | [BeyondSpring gets Nasdaq minimum bid price notice, has until March 16, 2027](https://aibio.space/news/beyondspring-gets-nasdaq-minimum-bid-price-notice-has-until-march-16/) |
| 2026-09-18 | Filana Therapeutics [FLNA](https://aibio.space/companies/filana-therapeutics/) | Deficiency notice | [Filana Therapeutics gets Nasdaq bid price notice, has until March 16, 2027](https://aibio.space/news/filana-therapeutics-gets-nasdaq-bid-price-notice-has-until-march-16/) |
| 2026-09-17 | Soligenix [SNGX](https://aibio.space/companies/soligenix/) | Reverse split | [Soligenix stockholders approve reverse split authority and share increase](https://aibio.space/news/soligenix-stockholders-approve-reverse-split-authority-share-increase/) |
| 2026-09-17 | Aditxt [ADTX](https://aibio.space/companies/aditxt/) | Delisting | [Nasdaq to delist Aditxt common stock after June suspension](https://aibio.space/news/nasdaq-delist-aditxt-common-stock-after-june-suspension/) |
| 2026-09-16 | Pasithea Therapeutics [KTTA](https://aibio.space/companies/pasithea-therapeutics/) | Listing change | [Pasithea warrants to expire on September 17, 2026](https://aibio.space/news/pasithea-warrants-expire-september-17-2026/) |
| 2026-09-16 | Matinas Biopharma Holdings [MTNB](https://aibio.space/companies/matinas-biopharma/) | Reverse split | [Matinas BioPharma sets one-for-fifteen reverse stock split](https://aibio.space/news/matinas-biopharma-sets-one-fifteen-reverse-stock-split/) |
| 2026-09-16 | Bone Biologics [BBLG](https://aibio.space/companies/bone-biologics/) | Reverse split | [Bone Biologics gets Nasdaq minimum bid price notice, has until March 9, 2027](https://aibio.space/news/bone-biologics-gets-nasdaq-minimum-bid-price-notice-has-until-march-9/) |
| 2026-09-08 | iSpecimen [ISPC](https://aibio.space/companies/ispecimen/) | Listing change | [iSpecimen gets until November 25, 2026 to meet Nasdaq equity rule](https://aibio.space/news/ispecimen-gets-until-november-25-2026-meet-nasdaq-equity-rule/) |
| 2026-09-08 | Can-Fite BioPharma [CANF](https://aibio.space/companies/can-fite-biopharma/) | Reverse split | [Can-Fite details 1-for-3,000 reverse split and ADS ratio change in 6-K](https://aibio.space/news/can-fite-details-1-3-000-reverse-split-ads-ratio-change-6/) |
| 2026-09-04 | iSpecimen [ISPC](https://aibio.space/companies/ispecimen/) | Listing change | [iSpecimen agrees to buy Foldlab AI software assets for $4,500,000](https://aibio.space/news/ispecimen-agrees-buy-foldlab-ai-software-assets-4-500-000/) |
| 2026-09-04 | Matinas Biopharma Holdings [MTNB](https://aibio.space/companies/matinas-biopharma/) | Deficiency notice | [Matinas BioPharma receives NYSE American stockholders' equity notice](https://aibio.space/news/matinas-biopharma-receives-nyse-american-stockholders-equity-notice/) |
| 2026-09-04 | IRulya Therapeutics, IRulya Therapeutics [IRLA](https://aibio.space/companies/irulya-therapeutics/)[QNCX](https://aibio.space/companies/irulya-therapeutics-qncx/) | Deficiency notice | [Quince Therapeutics (now IRulya Therapeutics) gets Nasdaq stockholders' equity deficiency notice](https://aibio.space/news/quince-therapeutics-now-irulya-therapeutics-gets-nasdaq-stockholders/) |
| 2026-09-04 | XORTX Therapeutics [XRTX](https://aibio.space/companies/xortx-therapeutics/) | Listing change | [XORTX Therapeutics files $2,500,000 paid promotion agreement with IR Agency](https://aibio.space/news/xortx-therapeutics-files-2-500-000-paid-promotion-agreement-ir-agency/) |
| 2026-09-03 | PRF Technologies [PRFX](https://aibio.space/companies/prf-technologies/) | Listing change | [PRF Technologies reports $8,526 thousand in cash at June 30, 2026](https://aibio.space/news/prf-technologies-reports-8-526-thousand-cash-june-30-2026/) |
| 2026-09-02 | BioRestorative Therapies [BRTX](https://aibio.space/companies/biorestorative-therapies/) | Reverse split | [BioRestorative gets Nasdaq late-filing notice, then does a 1-for-20 reverse split](https://aibio.space/news/biorestorative-gets-nasdaq-late-filing-notice-then-does-1-20-reverse/) |
| 2026-09-02 | Anavex Life Sciences [AVXL](https://aibio.space/companies/anavex-life-sciences/) | Regained compliance | [Anavex regains Nasdaq compliance after filing overdue 10-Qs on August 28, 2026](https://aibio.space/news/anavex-regains-nasdaq-compliance-after-filing-overdue-10-qs-august-28/) |
| 2026-09-02 | Quantum Biopharma [QNTM](https://aibio.space/companies/quantum-biopharma/) | Delisting | [Quantum BioPharma applies to delist Class B shares from the CSE](https://aibio.space/news/quantum-biopharma-applies-delist-class-b-shares-cse/) |
| 2026-09-01 | Earth Science Tech [ETST](https://aibio.space/companies/earth-science-tech/) | Reverse split | [Earth Science Tech holders approve reverse split authority for uplisting](https://aibio.space/news/earth-science-tech-holders-approve-reverse-split-authority-uplisting/) |
| 2026-08-28 | Oragenics [OGEN](https://aibio.space/companies/oragenics/) | Deficiency notice | [Oragenics receives NYSE American deficiency letter on equity](https://aibio.space/news/oragenics-receives-nyse-american-deficiency-letter-equity/) |
| 2026-08-28 | Glucotrack [GCTK](https://aibio.space/companies/glucotrack/) | Reverse split | [Glucotrack effects 1-for-15 reverse stock split](https://aibio.space/news/glucotrack-effects-1-15-reverse-stock-split/) |
| 2026-08-28 | ENvue Medical [FEED](https://aibio.space/companies/envue-medical/) | Reverse split | [ENvue Medical announces 1-for-12 reverse stock split effective September 1](https://aibio.space/news/envue-medical-announces-1-12-reverse-stock-split-effective-september-1/) |
| 2026-08-28 | Shuttle Pharmaceuticals Holdings [SHPH](https://aibio.space/companies/shuttle-pharmaceuticals/) | Deficiency notice | [Shuttle Pharmaceuticals gets Nasdaq deficiency notice over late Form 10-Q](https://aibio.space/news/shuttle-pharmaceuticals-gets-nasdaq-deficiency-notice-late-form-10/) |
| 2026-08-28 | China SXT Pharmaceuticals [SXTC](https://aibio.space/companies/china-sxt-pharmaceuticals/) | Listing change | [China SXT cuts pre-paid share purchase floor price back to $0.20 from $16.00](https://aibio.space/news/china-sxt-cuts-pre-paid-share-purchase-floor-price-back-0-20-16-00/) |
| 2026-08-27 | OSR Health [OSRH](https://aibio.space/companies/osr-health/) | Deficiency notice | [OSR Health hearing before Nasdaq Panel set for September 29](https://aibio.space/news/osr-health-hearing-before-nasdaq-panel-set-september-29/) |
| 2026-08-27 | Artelo Biosciences [ARTL](https://aibio.space/companies/artelo-biosciences/) | Reverse split | [Artelo Biosciences sets 1-for-9 reverse split, trading from August 31, 2026](https://aibio.space/news/artelo-biosciences-sets-1-9-reverse-split-trading-august-31-2026/) |
| 2026-08-27 | Valion Bio [VBIO](https://aibio.space/companies/valion-bio/) | Reverse split | [Valion sets 1-for-25 reverse stock split to regain Nasdaq compliance](https://aibio.space/news/valion-sets-1-25-reverse-stock-split-regain-nasdaq-compliance/) |
| 2026-08-27 | Korsana Biosciences [KRSA](https://aibio.space/companies/korsana-biosciences/) | Reverse split | [Cyclerion (now Korsana Biosciences) shareholders approve merger issuance and 1-for-7 reverse split](https://aibio.space/news/cyclerion-now-korsana-biosciences-shareholders-approve-merger-issuance/) |
| 2026-08-27 | Senti Biosciences Holdings [SNTI](https://aibio.space/companies/senti-biosciences/) | Deficiency notice | [Senti Biosciences gets two Nasdaq notices, on bid price and a $3.4M equity deficit](https://aibio.space/news/senti-biosciences-gets-two-nasdaq-notices-bid-price-3-4m-equity/) |
| 2026-08-26 | INTERPACE BIOSCIENCES, INC. [IDXG](https://aibio.space/companies/interpace-biosciences/) | Reverse split | [Interpace Biosciences sets 1-for-5 reverse stock split to support Nasdaq bid](https://aibio.space/news/interpace-biosciences-sets-1-5-reverse-stock-split-support-nasdaq-bid/) |
| 2026-08-25 | Ensysce Biosciences [ENSC](https://aibio.space/companies/ensysce-biosciences/) | Listing change | [Ensysce gets Nasdaq bid price extension to February 2027](https://aibio.space/news/ensysce-gets-nasdaq-bid-price-extension-february-2027/) |
| 2026-08-24 | Longeveron [LGVN](https://aibio.space/companies/longeveron/) | Reverse split | [Longeveron does a 1-for-10 reverse split to meet Nasdaq's $1 bid minimum](https://aibio.space/news/longeveron-does-1-10-reverse-split-meet-nasdaqs-1-bid-minimum/) |
| 2026-08-21 | VivoSim Labs, INC. [VIVS](https://aibio.space/companies/vivosim-labs/) | Reverse split | [VivoSim Labs receives Nasdaq bid price notice with February 2027 deadline](https://aibio.space/news/vivosim-labs-receives-nasdaq-bid-price-notice-february-2027-deadline/) |
| 2026-08-21 | Pasithea Therapeutics [KTTA](https://aibio.space/companies/pasithea-therapeutics/) | Listing change | [Pasithea receives Nasdaq extension to regain bid price compliance](https://aibio.space/news/pasithea-receives-nasdaq-extension-regain-bid-price-compliance/) |
| 2026-08-21 | Azitra [AZTR](https://aibio.space/companies/azitra/) | Regained compliance | [Azitra regains NYSE American continued listing compliance](https://aibio.space/news/azitra-regains-nyse-american-continued-listing-compliance/) |
| 2026-08-21 | Kairos Pharma [KAPA](https://aibio.space/companies/kairos-pharma/) | Reverse split | [Kairos Pharma sets 1-for-7 reverse stock split effective September 1, 2026](https://aibio.space/news/kairos-pharma-sets-1-7-reverse-stock-split-effective-september-1-2026/) |
| 2026-08-21 | Estrella Immunopharma [ESLA](https://aibio.space/companies/estrella-immunopharma/) | Deficiency notice | [Estrella Immunopharma gets Nasdaq minimum bid price notice, has until February 16, 2027 to comply](https://aibio.space/news/estrella-immunopharma-gets-nasdaq-minimum-bid-price-notice-has-until/) |
| 2026-08-21 | Adial Pharmaceuticals [ADIL](https://aibio.space/companies/adial-pharmaceuticals/) | Deficiency notice | [Adial Pharmaceuticals gets Nasdaq stockholders' equity notice, plan due October 2, 2026](https://aibio.space/news/adial-pharmaceuticals-gets-nasdaq-stockholders-equity-notice-plan-due/) |
| 2026-08-21 | Citius Pharmaceuticals, Citius Oncology [CTXR](https://aibio.space/companies/citius-pharmaceuticals/)[CTOR](https://aibio.space/companies/citius-oncology/) | Listing change | [Citius Pharmaceuticals gets Nasdaq extension to February 8, 2027 on bid price](https://aibio.space/news/citius-pharmaceuticals-gets-nasdaq-extension-february-8-2027-bid-price/) |
| 2026-08-20 | Profusa [PFSA](https://aibio.space/companies/profusa/) | Listing change | [Profusa reports Q2 2026 results and progress on G3 option](https://aibio.space/news/profusa-reports-q2-2026-results-progress-g3-option/) |
| 2026-08-20 | Curanex Pharmaceuticals [CURX](https://aibio.space/companies/curanex-pharmaceuticals/) | Reverse split | [Curanex regains Nasdaq bid-price compliance after 1-for-20 reverse split](https://aibio.space/news/curanex-regains-nasdaq-bid-price-compliance-after-1-20-reverse-split/) |
| 2026-08-19 | OSR Health [OSRH](https://aibio.space/companies/osr-health/) | Delisting | [OSR Health receives Nasdaq delisting determination, will request hearing](https://aibio.space/news/osr-health-receives-nasdaq-delisting-determination-will-request/) |
| 2026-08-19 | Mereo BioPharma Group [MREO](https://aibio.space/companies/mereo-biopharma/) | Listing change | [Mereo BioPharma gets second Nasdaq bid price period, to February 16, 2027](https://aibio.space/news/mereo-biopharma-gets-second-nasdaq-bid-price-period-february-16-2027/) |
| 2026-08-19 | Skye Bioscience [SKYE](https://aibio.space/companies/skye-bioscience/) | Deficiency notice | [Skye Bioscience gets Nasdaq notice: stockholders' equity was ($497,307)](https://aibio.space/news/skye-bioscience-gets-nasdaq-notice-stockholders-equity-was-497-307/) |
| 2026-08-18 | BullFrog AI Holdings [BFRG](https://aibio.space/companies/bullfrog-ai/) | Reverse split | [BullFrog AI granted Nasdaq second compliance period for bid price](https://aibio.space/news/bullfrog-ai-granted-nasdaq-second-compliance-period-bid-price/) |
| 2026-08-18 | Liminatus Pharma [LIMN](https://aibio.space/companies/liminatus-pharma/) | Reverse split | [Liminatus Pharma sets 1-for-50 reverse stock split to meet Nasdaq minimum bid price requirement](https://aibio.space/news/liminatus-pharma-sets-1-50-reverse-stock-split-meet-nasdaq-minimum-bid/) |
| 2026-08-17 | Lexaria Bioscience [LEXX](https://aibio.space/companies/lexaria-bioscience/) | Regained compliance | [Lexaria Bioscience regains Nasdaq bid price compliance, hearing cancelled](https://aibio.space/news/lexaria-bioscience-regains-nasdaq-bid-price-compliance-hearing/) |
| 2026-08-17 | XORTX Therapeutics [XRTX](https://aibio.space/companies/xortx-therapeutics/) | Listing change | [XORTX reports $994,045 in cash and a going-concern note for first half of 2026](https://aibio.space/news/xortx-reports-994-045-cash-going-concern-note-first-half-2026/) |
| 2026-08-14 | Adagio Medical Holdings [ADGM](https://aibio.space/companies/adagio-medical/) | Deficiency notice | [Adagio Medical receives Nasdaq notice on stockholders' equity](https://aibio.space/news/adagio-medical-receives-nasdaq-notice-stockholders-equity/) |
| 2026-08-14 | Silexion Therapeutics [SLXN](https://aibio.space/companies/silexion-therapeutics/) | Delisting | [Silexion had $2.2 million in cash at June 30 and flags going-concern doubt](https://aibio.space/news/silexion-had-2-2-million-cash-june-30-flags-going-concern-doubt/) |
| 2026-08-14 | CASI Pharmaceuticals [CASIF](https://aibio.space/companies/casi-pharmaceuticals/) | Delisting | [CASI Pharmaceuticals reports $3.8 million cash, details Nasdaq delisting and OTCQB quote](https://aibio.space/news/casi-pharmaceuticals-reports-3-8-million-cash-details-nasdaq-delisting/) |
| 2026-08-14 | Skye Bioscience [SKYE](https://aibio.space/companies/skye-bioscience/) | Listing change | [Skye Bioscience outlines Redx Pharma deal in August 14, 2026 investor deck](https://aibio.space/news/skye-bioscience-outlines-redx-pharma-deal-august-14-2026-investor-deck/) |
| 2026-08-13 | Satellos Bioscience [MSCL](https://aibio.space/companies/satellos-bioscience/) | Listing change | [Satellos reports $47,251 thousand net equity proceeds in first half of 2026](https://aibio.space/news/satellos-reports-47-251-thousand-net-equity-proceeds-first-half-2026/) |
| 2026-08-11 | Eloxx Pharmaceuticals [ELOX](https://aibio.space/companies/eloxx-pharmaceuticals/) | New listing | [Eloxx reports second-quarter results after a $66.0 million offering and Nasdaq uplisting](https://aibio.space/news/eloxx-reports-second-quarter-results-after-66-0-million-offering/) |
| 2026-08-10 | Lakewood-Amedex Biotherapeutics [LABT](https://aibio.space/companies/lakewood-amedex-biotherapeutics/) | Reverse split | [Lakewood-Amedex Biotherapeutics sets vote on share increase to 100,000,000 and reverse split](https://aibio.space/news/lakewood-amedex-biotherapeutics-sets-vote-share-increase-100-000-000/) |
| 2026-08-10 | Wave Life Sciences [WVE](https://aibio.space/companies/wave-life-sciences/) | Delisting | [Wave Life Sciences Ltd. (now Wave Life Sciences, Inc.) files Form 15 to end SEC reporting](https://aibio.space/news/wave-life-sciences-ltd-now-wave-life-sciences-inc-files-form-15-end/) |
| 2026-08-07 | Niki BioSolutions [NIKI](https://aibio.space/companies/niki-biosolutions/) | Regained compliance | [Aptorum Group (now Niki BioSolutions) regains Nasdaq bid price compliance](https://aibio.space/news/aptorum-group-now-niki-biosolutions-regains-nasdaq-bid-price/) |
| 2026-08-06 | Zhengye Biotechnology Holding [ZYBT](https://aibio.space/companies/zhengye-biotechnology/) | Regained compliance | [Zhengye Biotechnology regains Nasdaq bid price compliance](https://aibio.space/news/zhengye-biotechnology-regains-nasdaq-bid-price-compliance/) |
| 2026-08-05 | Genprex [GNPX](https://aibio.space/companies/genprex/) | Regained compliance | [Genprex regains Nasdaq bid price compliance, panel oversight runs to December 7](https://aibio.space/news/genprex-regains-nasdaq-bid-price-compliance-panel-oversight-runs/) |
| 2026-08-05 | Vistagen Therapeutics [VTGN](https://aibio.space/companies/vistagen-therapeutics/) | Listing change | [Vistagen gets 180-day Nasdaq extension, until February 1, 2027, on minimum bid price rule](https://aibio.space/news/vistagen-gets-180-day-nasdaq-extension-until-february-1-2027-minimum/) |
| 2026-08-05 | Aura Biosciences [AURA](https://aibio.space/companies/aura-biosciences/) | Listing change | [Aura Biosciences holders approve raising authorized shares to 500,000,000](https://aibio.space/news/aura-biosciences-holders-approve-raising-authorized-shares-500-000-000/) |
| 2026-08-03 | AEON Biopharma [AEON](https://aibio.space/companies/aeon-biopharma/) | Regained compliance | [AEON regains NYSE American compliance after July offering](https://aibio.space/news/aeon-regains-nyse-american-compliance-after-july-offering/) |
| 2026-07-31 | AETHLON MEDICAL INC [AEMD](https://aibio.space/companies/aethlon-medical/) | Reverse split | [Aethlon effects 1-for-5 reverse stock split effective July 31](https://aibio.space/news/aethlon-effects-1-5-reverse-stock-split-effective-july-31/) |
| 2026-07-31 | MIRA Pharmaceuticals [MIRA](https://aibio.space/companies/mira-pharmaceuticals/) | Deficiency notice | [Mira Pharmaceuticals gets Nasdaq bid price deficiency notice; deadline is January 25, 2027](https://aibio.space/news/mira-pharmaceuticals-gets-nasdaq-bid-price-deficiency-notice-deadline/) |
| 2026-07-31 | PDS Biotechnology [PDSB](https://aibio.space/companies/pds-biotechnology/) | Reverse split | [PDS Biotechnology gets Nasdaq minimum bid price deficiency letter, has until January 26, 2027](https://aibio.space/news/pds-biotechnology-gets-nasdaq-minimum-bid-price-deficiency-letter-has/) |
| 2026-07-31 | Evogene [EVGN](https://aibio.space/companies/evogene/) | Reverse split | [Evogene calls September 4 meeting on director slates, share capital and reverse split](https://aibio.space/news/evogene-calls-september-4-meeting-director-slates-share-capital/) |
| 2026-07-30 | Genprex [GNPX](https://aibio.space/companies/genprex/) | Deficiency notice | [Nasdaq panel grants Genprex an exception on the $1.00 bid price rule](https://aibio.space/news/nasdaq-panel-grants-genprex-exception-1-00-bid-price-rule/) |
| 2026-07-30 | Alterity Therapeutics [ATH](https://aibio.space/companies/alterity-therapeutics/) | Listing change | [Alterity reports A$37.3 million cash after 1-for-50 share consolidation](https://aibio.space/news/alterity-reports-37-3-million-cash-after-1-50-share-consolidation/) |
| 2026-07-30 | Lexaria Bioscience [LEXX](https://aibio.space/companies/lexaria-bioscience/) | Reverse split | [Lexaria sets 1-for-15 reverse split for August 3, 2026 to meet Nasdaq bid rule](https://aibio.space/news/lexaria-sets-1-15-reverse-split-august-3-2026-meet-nasdaq-bid-rule/) |
| 2026-07-29 | Traws Pharma [TRAW](https://aibio.space/companies/traws-pharma/) | Deficiency notice | [Traws Pharma receives Nasdaq notice on $1.00 minimum bid price](https://aibio.space/news/traws-pharma-receives-nasdaq-notice-1-00-minimum-bid-price/) |
| 2026-07-29 | Celularity [CELU](https://aibio.space/companies/celularity/) | Deficiency notice | [Celularity gets Nasdaq minimum bid price deficiency notice, has until January 19, 2027 to comply](https://aibio.space/news/celularity-gets-nasdaq-minimum-bid-price-deficiency-notice-has-until/) |
| 2026-07-29 | Earth Science Tech [ETST](https://aibio.space/companies/earth-science-tech/) | Reverse split | [Earth Science Tech to ask holders for advisory vote on reverse split for uplisting](https://aibio.space/news/earth-science-tech-ask-holders-advisory-vote-reverse-split-uplisting/) |
| 2026-07-28 | BGM Group [BGM](https://aibio.space/companies/bgm/) | Regained compliance | [BGM Group regains Nasdaq compliance after filing its late 20-F](https://aibio.space/news/bgm-group-regains-nasdaq-compliance-after-filing-late-20/) |
| 2026-07-27 | Calidi Biotherapeutics [CLDI](https://aibio.space/companies/calidi-biotherapeutics/) | Reverse split | [Calidi Biotherapeutics effects 1-for-16 reverse stock split](https://aibio.space/news/calidi-biotherapeutics-effects-1-16-reverse-stock-split/) |
| 2026-07-24 | VivoSim Labs, INC. [VIVS](https://aibio.space/companies/vivosim-labs/) | Deficiency notice | [VivoSim Labs gets Nasdaq equity notice and cites July warrant exercises](https://aibio.space/news/vivosim-labs-gets-nasdaq-equity-notice-cites-july-warrant-exercises/) |
| 2026-07-24 | Apimeds Pharmaceuticals US [APUS](https://aibio.space/companies/apimeds-pharmaceuticals-us/) | Reverse split | [Apimeds Pharmaceuticals reverse stock split took effect July 24](https://aibio.space/news/apimeds-pharmaceuticals-reverse-stock-split-took-effect-july-24/) |
| 2026-07-24 | Labiana Health SA [LAB](https://aibio.space/companies/labiana-health/) | Deficiency notice | [Standard BioTools gets Nasdaq minimum bid price notice, has until January 19, 2027](https://aibio.space/news/standard-biotools-gets-nasdaq-minimum-bid-price-notice-has-until/) |
| 2026-07-24 | Oncolytics Biotech [ONCY](https://aibio.space/companies/oncolytics-biotech/) | Deficiency notice | [Oncolytics Biotech gets Nasdaq minimum bid price deficiency notice, has until January 19, 2027](https://aibio.space/news/oncolytics-biotech-gets-nasdaq-minimum-bid-price-deficiency-notice-has/) |
| 2026-07-24 | FibroBiologics [FBLG](https://aibio.space/companies/fibrobiologics/) | Reverse split | [FibroBiologics gets Nasdaq delisting determination over $1.00 minimum bid price, plans appeal](https://aibio.space/news/fibrobiologics-gets-nasdaq-delisting-determination-1-00-minimum-bid/) |
| 2026-07-21 | XTL Biopharmaceuticals [XTLB](https://aibio.space/companies/xtl-biopharmaceuticals/) | Regained compliance | [XTL Biopharmaceuticals regains Nasdaq compliance, faces one-year panel monitor](https://aibio.space/news/xtl-biopharmaceuticals-regains-nasdaq-compliance-faces-one-year-panel/) |
| 2026-07-20 | Rockwell Medical [RMTI](https://aibio.space/companies/rockwell-medical/) | Regained compliance | [Rockwell Medical regains Nasdaq bid price compliance, matter closed](https://aibio.space/news/rockwell-medical-regains-nasdaq-bid-price-compliance-matter-closed/) |
| 2026-07-17 | Dare Bioscience [DARE](https://aibio.space/companies/dare-bioscience/) | Delisting | [Daré Bioscience gets Nasdaq notice on stockholders' equity, plans hearing](https://aibio.space/news/dare-bioscience-gets-nasdaq-notice-stockholders-equity-plans-hearing/) |
| 2026-07-16 | CDT Equity [CDT](https://aibio.space/companies/cdt-equity/) | Reverse split | [CDT Equity to do 1-for-10 reverse stock split effective July 17](https://aibio.space/news/cdt-equity-do-1-10-reverse-stock-split-effective-july-17/) |
| 2026-07-14 | Genprex [GNPX](https://aibio.space/companies/genprex/) | Reverse split | [Genprex plans a 1-for-22 reverse stock split effective July 16](https://aibio.space/news/genprex-plans-1-22-reverse-stock-split-effective-july-16/) |
| 2026-07-14 | Apollomics [APLM](https://aibio.space/companies/apollomics/) | Regained compliance | [Apollomics regains Nasdaq compliance on $35 million market value rule](https://aibio.space/news/apollomics-regains-nasdaq-compliance-35-million-market-value-rule/) |
| 2026-07-13 | Apimeds Pharmaceuticals US [APUS](https://aibio.space/companies/apimeds-pharmaceuticals-us/) | Reverse split | [Apimeds Pharmaceuticals sets reverse split date of July 24](https://aibio.space/news/apimeds-pharmaceuticals-sets-reverse-split-date-july-24/) |
| 2026-07-09 | ENDRA Life Sciences [NDRA](https://aibio.space/companies/endra-life-sciences/) | Regained compliance | [ENDRA regains Nasdaq stockholders' equity compliance](https://aibio.space/news/endra-regains-nasdaq-stockholders-equity-compliance/) |
| 2026-07-08 | AquaBounty Technologies [AQB](https://aibio.space/companies/aquabounty-technologies/) | Reverse split | [AquaBounty's board declines reverse stock split for now](https://aibio.space/news/aquabountys-board-declines-reverse-stock-split-now/) |
| 2026-07-06 | Oragenics [OGEN](https://aibio.space/companies/oragenics/) | Reverse split | [Oragenics names John Spencer CFO and reports annual meeting votes](https://aibio.space/news/oragenics-names-john-spencer-cfo-reports-annual-meeting-votes/) |
| 2026-07-06 | FOXO TECHNOLOGIES INC. [FOXO](https://aibio.space/companies/foxo-technologies/) | Reverse split | [FOXO CEO gives mid-year 2026 update and says uplisting is under consideration](https://aibio.space/news/foxo-ceo-gives-mid-year-2026-update-says-uplisting-under-consideration/) |
| 2026-07-06 | COSCIENS Biopharma [CSCI](https://aibio.space/companies/cosciens-biopharma/) | Delisting | [COSCIENS Biopharma files Form 15 to end SEC reporting duties](https://aibio.space/news/cosciens-biopharma-files-form-15-end-sec-reporting-duties/) |
| 2026-07-06 | Gelteq [GELS](https://aibio.space/companies/gelteq/) | Listing change | [Gelteq closes second debt tranche, receiving $2.5 million net of discount](https://aibio.space/news/gelteq-closes-second-debt-tranche-receiving-2-5-million-net-discount/) |
| 2026-07-01 | FOXO TECHNOLOGIES INC. [FOXO](https://aibio.space/companies/foxo-technologies/) | Reverse split | [FOXO completes 1-for-3,000 reverse stock split](https://aibio.space/news/foxo-completes-1-3-000-reverse-stock-split/) |
| 2026-06-30 | HCW Biologics [HCWB](https://aibio.space/companies/hcw-biologics/) | Reverse split | [HCW Biologics regains Nasdaq bid price compliance, faces monitor until June 17, 2027](https://aibio.space/news/hcw-biologics-regains-nasdaq-bid-price-compliance-faces-monitor-until/) |
| 2026-06-29 | Rockwell Medical [RMTI](https://aibio.space/companies/rockwell-medical/) | Reverse split | [Rockwell Medical sets 1-for-10 reverse stock split for July 1, 2026](https://aibio.space/news/rockwell-medical-sets-1-10-reverse-stock-split-july-1-2026/) |
| 2026-06-26 | Matinas Biopharma Holdings [MTNB](https://aibio.space/companies/matinas-biopharma/) | Deficiency notice | [Matinas BioPharma receives NYSE American equity notice, plan accepted](https://aibio.space/news/matinas-biopharma-receives-nyse-american-equity-notice-plan-accepted/) |
| 2026-06-23 | Nuwellis [NUWE](https://aibio.space/companies/nuwellis/) | Reverse split | [Nuwellis to effect one-for-thirty-five reverse stock split on June 25](https://aibio.space/news/nuwellis-effect-one-thirty-five-reverse-stock-split-june-25/) |
| 2026-06-22 | Akebia Therapeutics [AKBA](https://aibio.space/companies/akebia-therapeutics/) | Listing change | [Akebia stockholders approve raising authorized common shares to 500,000,000](https://aibio.space/news/akebia-stockholders-approve-raising-authorized-common-shares-500-000/) |
| 2026-06-22 | Allogene Therapeutics [ALLO](https://aibio.space/companies/allogene-therapeutics/) | Listing change | [Allogene holders approve 800,000,000 shares; files ATM supplement for up to $135.0 million](https://aibio.space/news/allogene-holders-approve-800-000-000-shares-files-atm-supplement-up/) |
| 2026-06-22 | CytomX Therapeutics [CTMX](https://aibio.space/companies/cytomx-therapeutics/) | Listing change | [CytomX holders approve 600,000,000 authorized shares and larger equity plans](https://aibio.space/news/cytomx-holders-approve-600-000-000-authorized-shares-larger-equity/) |
| 2026-06-22 | Eledon Pharmaceuticals [ELDN](https://aibio.space/companies/eledon-pharmaceuticals/) | Listing change | [Eledon holders approve raising authorized common shares to 450,000,000](https://aibio.space/news/eledon-holders-approve-raising-authorized-common-shares-450-000-000/) |
| 2026-06-22 | Provectus Biopharmaceuticals [PVCT](https://aibio.space/companies/provectus-biopharmaceuticals/) | Reverse split | [Provectus holders authorize reverse split of between 1-for-10 and 1-for-50](https://aibio.space/news/provectus-holders-authorize-reverse-split-between-1-10-1-50/) |
| 2026-06-18 | Silo Pharma [SILO](https://aibio.space/companies/silo-pharma/) | Regained compliance | [Silo Pharma regains Nasdaq minimum bid price compliance](https://aibio.space/news/silo-pharma-regains-nasdaq-minimum-bid-price-compliance/) |
| 2026-06-18 | Dyadic International [DYAI](https://aibio.space/companies/dyadic-international/) | Delisting | [Dyadic International gets Nasdaq delisting notice over bid price, plans hearing](https://aibio.space/news/dyadic-international-gets-nasdaq-delisting-notice-bid-price-plans/) |
| 2026-06-18 | Xencor [XNCR](https://aibio.space/companies/xencor/) | Listing change | [Xencor holders approve 4,000,000-share increase to 2023 equity plan](https://aibio.space/news/xencor-holders-approve-4-000-000-share-increase-2023-equity-plan/) |
| 2026-06-17 | Lakewood-Amedex Biotherapeutics [LABT](https://aibio.space/companies/lakewood-amedex-biotherapeutics/) | Reverse split | [Lakewood-Amedex Biotherapeutics sets 1-for-10 reverse split, trading June 22, 2026](https://aibio.space/news/lakewood-amedex-biotherapeutics-sets-1-10-reverse-split-trading-june/) |
| 2026-06-15 | AIM ImmunoTech [AIM](https://aibio.space/companies/aim-immunotech/) | Regained compliance | [AIM ImmunoTech regains NYSE American stockholders' equity compliance](https://aibio.space/news/aim-immunotech-regains-nyse-american-stockholders-equity-compliance/) |
| 2026-06-15 | Rockwell Medical [RMTI](https://aibio.space/companies/rockwell-medical/) | Reverse split | [Rockwell Medical holders approve reverse stock split amendment](https://aibio.space/news/rockwell-medical-holders-approve-reverse-stock-split-amendment/) |
| 2026-06-12 | Adagio Medical Holdings [ADGM](https://aibio.space/companies/adagio-medical/) | Deficiency notice | [Adagio Medical gets Nasdaq bid price notice, has until December 9](https://aibio.space/news/adagio-medical-gets-nasdaq-bid-price-notice-has-until-december-9/) |
| 2026-06-12 | Genprex [GNPX](https://aibio.space/companies/genprex/) | Reverse split | [Nasdaq staff says Genprex is not eligible for a bid price compliance period](https://aibio.space/news/nasdaq-staff-says-genprex-not-eligible-bid-price-compliance-period/) |
| 2026-06-12 | Soligenix [SNGX](https://aibio.space/companies/soligenix/) | Deficiency notice | [Soligenix gets Nasdaq minimum bid price notice, ends HyBryte program](https://aibio.space/news/soligenix-gets-nasdaq-minimum-bid-price-notice-ends-hybryte-program/) |
| 2026-06-12 | BioCardia [BCDA](https://aibio.space/companies/biocardia/) | Listing change | [BioCardia believes it regained Nasdaq stockholders' equity compliance after at-the-market sales](https://aibio.space/news/biocardia-believes-regained-nasdaq-stockholders-equity-compliance-2/) |
| 2026-06-12 | Celularity [CELU](https://aibio.space/companies/celularity/) | Delisting | [Celularity gets Nasdaq notice on market value of listed securities, has until December 7, 2026](https://aibio.space/news/celularity-gets-nasdaq-notice-market-value-listed-securities-has-until/) |
| 2026-06-12 | Annexon [ANNX](https://aibio.space/companies/annexon/) | Listing change | [Annexon holders approve raising authorized common shares to 500,000,000](https://aibio.space/news/annexon-holders-approve-raising-authorized-common-shares-500-000-000/) |
| 2026-06-12 | Cuprina Holdings (Cayman) [CUPR](https://aibio.space/companies/cuprina-cayman/) | Regained compliance | [Cuprina Holdings regains Nasdaq compliance, July 7, 2026 hearing cancelled](https://aibio.space/news/cuprina-holdings-regains-nasdaq-compliance-july-7-2026-hearing/) |
| 2026-06-10 | Niki BioSolutions [NIKI](https://aibio.space/companies/niki-biosolutions/) | Listing change | [Aptorum Group (now Niki BioSolutions) shareholders approve DiamiR merger](https://aibio.space/news/aptorum-group-now-niki-biosolutions-shareholders-approve-diamir-merger/) |
| 2026-06-10 | Solid Biosciences [SLDB](https://aibio.space/companies/solid-biosciences/) | Listing change | [Solid Biosciences holders approve doubling authorized shares to 480,000,000](https://aibio.space/news/solid-biosciences-holders-approve-doubling-authorized-shares-480-000/) |
| 2026-06-10 | Voyager Therapeutics [VYGR](https://aibio.space/companies/voyager-therapeutics/) | Listing change | [Voyager Therapeutics holders approve doubling common stock to 240,000,000 shares](https://aibio.space/news/voyager-therapeutics-holders-approve-doubling-common-stock-240-000-000/) |
| 2026-06-09 | Bluejay Diagnostics [BJDX](https://aibio.space/companies/bluejay-diagnostics/) | Reverse split | [Bluejay stockholders approve reverse split authority](https://aibio.space/news/bluejay-stockholders-approve-reverse-split-authority/) |
| 2026-06-09 | Jasper Therapeutics [JSPR](https://aibio.space/companies/jasper-therapeutics/) | Reverse split | [Jasper Therapeutics receives Nasdaq minimum bid price notice, has until November 30, 2026](https://aibio.space/news/jasper-therapeutics-receives-nasdaq-minimum-bid-price-notice-has-until/) |
| 2026-06-09 | Relay Therapeutics [RLAY](https://aibio.space/companies/relay-therapeutics/) | Listing change | [Relay Therapeutics holders approve raising authorized shares to 450,000,000](https://aibio.space/news/relay-therapeutics-holders-approve-raising-authorized-shares-450-000/) |
| 2026-06-08 | MetaVia [MTVA](https://aibio.space/companies/metavia/) | Reverse split | [MetaVia shareholders approve reverse split range of 1-for-5 to 1-for-22](https://aibio.space/news/metavia-shareholders-approve-reverse-split-range-1-5-1-22/) |
| 2026-06-08 | aTyr Pharma [ATYR](https://aibio.space/companies/atyr-pharma/) | Reverse split | [aTyr Pharma gets 180 more days from Nasdaq to meet $1.00 minimum bid price](https://aibio.space/news/atyr-pharma-gets-180-more-days-nasdaq-meet-1-00-minimum-bid-price/) |
| 2026-06-08 | Savara [SVRA](https://aibio.space/companies/savara/) | Listing change | [Savara holders approve doubling authorized shares to 600,000,000](https://aibio.space/news/savara-holders-approve-doubling-authorized-shares-600-000-000/) |
| 2026-06-04 | OnKure Therapeutics [OKUR](https://aibio.space/companies/onkure-therapeutics/) | Listing change | [OnKure Therapeutics holders approve equity plan adding 3,231,638 shares](https://aibio.space/news/onkure-therapeutics-holders-approve-equity-plan-adding-3-231-638/) |
| 2026-06-04 | Trevi Therapeutics [TRVI](https://aibio.space/companies/trevi-therapeutics/) | Listing change | [Trevi Therapeutics holders approve doubling authorized shares to 400,000,000](https://aibio.space/news/trevi-therapeutics-holders-approve-doubling-authorized-shares-400-000/) |
| 2026-06-01 | Silo Pharma [SILO](https://aibio.space/companies/silo-pharma/) | Reverse split | [Silo Pharma completes 1-for-15 reverse stock split](https://aibio.space/news/silo-pharma-completes-1-15-reverse-stock-split/) |
| 2026-05-29 | Enveric Biosciences [ENVB](https://aibio.space/companies/enveric-biosciences/) | Reverse split | [Enveric stockholders vote on reverse split range and larger authorized share count](https://aibio.space/news/enveric-stockholders-vote-reverse-split-range-larger-authorized-share/) |
| 2026-05-28 | Abpro Holdings [ABPO](https://aibio.space/companies/abpro/) | Delisting | [Nasdaq council upholds Abpro Holdings delisting; OTC Pink quotation expected](https://aibio.space/news/nasdaq-council-upholds-abpro-holdings-delisting-otc-pink-quotation/) |
| 2026-05-28 | CDT Equity [CDT](https://aibio.space/companies/cdt-equity/) | Deficiency notice | [CDT Equity gets Nasdaq notice over late first-quarter 10-Q](https://aibio.space/news/cdt-equity-gets-nasdaq-notice-late-first-quarter-10/) |
| 2026-05-28 | Silexion Therapeutics [SLXN](https://aibio.space/companies/silexion-therapeutics/) | Reverse split | [Silexion completes 1-for-10 reverse split, its third since late 2024](https://aibio.space/news/silexion-completes-1-10-reverse-split-third-since-late-2024/) |
| 2026-05-27 | Aditxt [ADTX](https://aibio.space/companies/aditxt/) | Deficiency notice | [Nasdaq letter says Aditxt falls below $2,500,000 equity minimum](https://aibio.space/news/nasdaq-letter-says-aditxt-falls-below-2-500-000-equity-minimum/) |
| 2026-05-27 | Dermata Therapeutics [DRMA](https://aibio.space/companies/dermata-therapeutics/) | Listing change | [Dermata shareholders approve warrant repricing and larger equity plan](https://aibio.space/news/dermata-shareholders-approve-warrant-repricing-larger-equity-plan/) |
| 2026-05-27 | Sintofarm SA Bucuresti [SINT](https://aibio.space/companies/sintofarm-bucuresti/) | Deficiency notice | [SINTX Technologies gets Nasdaq stockholders' equity deficiency notice, plan due July 6, 2026](https://aibio.space/news/sintx-technologies-gets-nasdaq-stockholders-equity-deficiency-notice/) |
| 2026-05-26 | Bio-Path Holdings [BPTH](https://aibio.space/companies/bio-path/) | Reverse split | [Bio-Path cancels planned reverse split and approves treasury plan](https://aibio.space/news/bio-path-cancels-planned-reverse-split-approves-treasury-plan/) |
| 2026-05-22 | Ensysce Biosciences [ENSC](https://aibio.space/companies/ensysce-biosciences/) | Delisting | [Ensysce receives Nasdaq notice on stockholders' equity requirement](https://aibio.space/news/ensysce-receives-nasdaq-notice-stockholders-equity-requirement/) |
| 2026-05-22 | FOXO TECHNOLOGIES INC. [FOXO](https://aibio.space/companies/foxo-technologies/) | Reverse split | [FOXO settles J.H. Darbie fees and seeks a reverse stock split](https://aibio.space/news/foxo-settles-j-h-darbie-fees-seeks-reverse-stock-split/) |
| 2026-05-22 | TransCode Therapeutics [RNAZ](https://aibio.space/companies/transcode-therapeutics/) | Deficiency notice | [TransCode Therapeutics gets Nasdaq stockholders' equity deficiency notice](https://aibio.space/news/transcode-therapeutics-gets-nasdaq-stockholders-equity-deficiency/) |
| 2026-05-22 | Tempest Therapeutics [TPST](https://aibio.space/companies/tempest-therapeutics/) | Deficiency notice | [Tempest Therapeutics gets Nasdaq notice on stockholders' equity, flags board independence gap](https://aibio.space/news/tempest-therapeutics-gets-nasdaq-notice-stockholders-equity-flags/) |
| 2026-05-19 | Oncopeptides AB [ONCO](https://aibio.space/companies/oncopeptides/) | Reverse split | [Onconetix to effect 1-for-10 reverse stock split on May 21, 2026](https://aibio.space/news/onconetix-effect-1-10-reverse-stock-split-may-21-2026/) |
| 2026-05-19 | Clearmind Medicine [CMND](https://aibio.space/companies/clearmind-medicine/) | Reverse split | [Clearmind Medicine announces 1-for-10 reverse split, effective May 21, 2026](https://aibio.space/news/clearmind-medicine-announces-1-10-reverse-split-effective-may-21-2026/) |
| 2026-05-19 | Larimar Therapeutics [LRMR](https://aibio.space/companies/larimar-therapeutics/) | Listing change | [Larimar Therapeutics holders approve raising authorized shares to 215,000,000](https://aibio.space/news/larimar-therapeutics-holders-approve-raising-authorized-shares-215-000/) |
| 2026-05-18 | Palatin Technologies [PTN](https://aibio.space/companies/palatin-technologies/) | Listing change | [Palatin Technologies to move stock listing from NYSE American to Nasdaq Capital Market](https://aibio.space/news/palatin-technologies-move-stock-listing-nyse-american-nasdaq-capital/) |
| 2026-05-18 | NervGen Pharma [NGEN](https://aibio.space/companies/nervgen-pharma/) | Listing change | [NervGen reports $16.6 million cash and investments after Nasdaq listing](https://aibio.space/news/nervgen-reports-16-6-million-cash-investments-after-nasdaq-listing/) |
| 2026-05-15 | Skye Bioscience [SKYE](https://aibio.space/companies/skye-bioscience/) | Deficiency notice | [Skye Bioscience gets Nasdaq notice: stockholders' equity of $9,011,804 is below $10,000,000 minimum](https://aibio.space/news/skye-bioscience-gets-nasdaq-notice-stockholders-equity-9-011-804-below/) |
| 2026-05-15 | Rani Therapeutics Holdings [RANI](https://aibio.space/companies/rani-therapeutics/) | Deficiency notice | [Rani Therapeutics gets Nasdaq minimum bid price notice, CFO Svai Sanford to resign](https://aibio.space/news/rani-therapeutics-gets-nasdaq-minimum-bid-price-notice-cfo-svai/) |
| 2026-05-15 | Enlivex [ENLV](https://aibio.space/companies/enlivex/) | Deficiency notice | [Enlivex gets Nasdaq bid price notice, has until November 9, 2026](https://aibio.space/news/enlivex-gets-nasdaq-bid-price-notice-has-until-november-9-2026/) |
| 2026-05-14 | Aditxt [ADTX](https://aibio.space/companies/aditxt/) | Reverse split | [Aditxt plans 1-for-27 reverse stock split effective May 18](https://aibio.space/news/aditxt-plans-1-27-reverse-stock-split-effective-may-18/) |
| 2026-05-14 | Bio Green Med Solution [BGMS](https://aibio.space/companies/bio-green-med-solution/) | Listing change | [Preferred stock removed from Nasdaq as Bio Green Med reports first-quarter results](https://aibio.space/news/preferred-stock-removed-nasdaq-bio-green-med-reports-first-quarter/) |
| 2026-05-14 | Cuprina Holdings (Cayman) [CUPR](https://aibio.space/companies/cuprina-cayman/) | Listing change | [Cuprina shareholders approve share consolidation and higher Class B voting rights](https://aibio.space/news/cuprina-shareholders-approve-share-consolidation-higher-class-b-voting/) |
| 2026-05-13 | LogicMark [LGMK](https://aibio.space/companies/logicmark/) | Listing change | [LogicMark revenue rises 24% in first quarter 2026](https://aibio.space/news/logicmark-revenue-rises-24-percent-first-quarter-2026/) |
| 2026-05-11 | PureTech Health [PRTC](https://aibio.space/companies/puretech-health/) | Delisting | [PureTech Health PLC files Form 25 to delist its ADSs from Nasdaq](https://aibio.space/news/puretech-health-plc-files-form-25-delist-adss-nasdaq/) |
| 2026-05-11 | SciSparc [SPRC](https://aibio.space/companies/scisparc/) | Delisting | [SciSparc gets conditional Nasdaq compliance letter on stockholders' equity](https://aibio.space/news/scisparc-gets-conditional-nasdaq-compliance-letter-stockholders-equity/) |
| 2026-05-08 | iSpecimen [ISPC](https://aibio.space/companies/ispecimen/) | Listing change | [iSpecimen prices $2.5 million private placement at $5.12 per share](https://aibio.space/news/ispecimen-prices-2-5-million-private-placement-5-12-share/) |
| 2026-05-08 | Humacyte [HUMA](https://aibio.space/companies/humacyte/) | Deficiency notice | [Humacyte gets Nasdaq minimum bid price deficiency notice, has until November 2, 2026](https://aibio.space/news/humacyte-gets-nasdaq-minimum-bid-price-deficiency-notice-has-until/) |
| 2026-04-30 | Enveric Biosciences [ENVB](https://aibio.space/companies/enveric-biosciences/) | Reverse split | [Enveric corrects reverse split maximum in proxy materials to 1-for-15](https://aibio.space/news/enveric-corrects-reverse-split-maximum-proxy-materials-1-15/) |
| 2026-04-30 | Rockwell Medical [RMTI](https://aibio.space/companies/rockwell-medical/) | Reverse split | [Rockwell Medical to put reverse stock split to a vote at June 12, 2026 meeting](https://aibio.space/news/rockwell-medical-put-reverse-stock-split-vote-june-12-2026-meeting/) |
| 2026-04-29 | CorMedix [CRMD](https://aibio.space/companies/cormedix/) | Listing change | [CorMedix asks holders to ratify past changes to preferred stock terms](https://aibio.space/news/cormedix-asks-holders-ratify-past-changes-preferred-stock-terms/) |
| 2026-04-29 | PureTech Health [PRTC](https://aibio.space/companies/puretech-health/) | Delisting | [PureTech to delist ADSs from Nasdaq and keep its primary London listing](https://aibio.space/news/puretech-delist-adss-nasdaq-keep-primary-london-listing/) |
| 2026-04-28 | Citius Oncology [CTOR](https://aibio.space/companies/citius-oncology/) | Deficiency notice | [Citius Oncology gets Nasdaq minimum bid price deficiency notice, has until October 19, 2026](https://aibio.space/news/citius-oncology-gets-nasdaq-minimum-bid-price-deficiency-notice-has/) |
| 2026-04-28 | InflaRx [IFRX](https://aibio.space/companies/inflarx-n-v/) | Regained compliance | [InflaRx regains Nasdaq bid price compliance](https://aibio.space/news/inflarx-regains-nasdaq-bid-price-compliance/) |
| 2026-04-24 | iSpecimen [ISPC](https://aibio.space/companies/ispecimen/) | Reverse split | [iSpecimen plans 1-for-40 reverse stock split effective April 27, 2026](https://aibio.space/news/ispecimen-plans-1-40-reverse-stock-split-effective-april-27-2026/) |
| 2026-04-22 | Tevogen [TVGN](https://aibio.space/companies/tevogen/) | Deficiency notice | [Tevogen Bio Holdings (now Tevogen Inc.) gets two Nasdaq deficiency notices on market value](https://aibio.space/news/tevogen-bio-holdings-now-tevogen-inc-gets-two-nasdaq-deficiency/) |
| 2026-04-22 | Apimeds Pharmaceuticals US [APUS](https://aibio.space/companies/apimeds-pharmaceuticals-us/) | Deficiency notice | [Apimeds Pharmaceuticals gets NYSE American late filing notice for 2025 Form 10-K](https://aibio.space/news/apimeds-pharmaceuticals-gets-nyse-american-late-filing-notice-2025/) |
| 2026-04-22 | Cue Biopharma [CUE](https://aibio.space/companies/cue-biopharma/) | Reverse split | [Cue Biopharma sets 1-for-30 reverse stock split for April 23, 2026](https://aibio.space/news/cue-biopharma-sets-1-30-reverse-stock-split-april-23-2026/) |
| 2026-04-16 | Altimmune [ALT](https://aibio.space/companies/altimmune/) | Listing change | [Altimmune holders approve doubling authorized shares to 400,000,000](https://aibio.space/news/altimmune-holders-approve-doubling-authorized-shares-400-000-000/) |
| 2026-04-15 | Mustang Bio [MBIO](https://aibio.space/companies/mustang-bio/) | Deficiency notice | [Mustang Bio receives Nasdaq bid price deficiency notice](https://aibio.space/news/mustang-bio-receives-nasdaq-bid-price-deficiency-notice/) |
| 2026-04-13 | Cue Biopharma [CUE](https://aibio.space/companies/cue-biopharma/) | Reverse split | [Cue Biopharma holders approve reverse split range of 1-for-30 to 1-for-50](https://aibio.space/news/cue-biopharma-holders-approve-reverse-split-range-1-30-1-50/) |
| 2026-04-09 | Alaunos Therapeutics [TCRT](https://aibio.space/companies/alaunos-therapeutics/) | Deficiency notice | [Alaunos receives Nasdaq notice on stockholders' equity requirement](https://aibio.space/news/alaunos-receives-nasdaq-notice-stockholders-equity-requirement/) |
| 2026-04-09 | Kyntra Bio [KYNB](https://aibio.space/companies/kyntra-bio/) | Deficiency notice | [Kyntra Bio gets Nasdaq deficiency notice on $50 million total assets and revenue rule](https://aibio.space/news/kyntra-bio-gets-nasdaq-deficiency-notice-50-million-total-assets/) |
| 2026-04-09 | Gossamer Bio [GOSS](https://aibio.space/companies/gossamer-bio/) | Deficiency notice | [Gossamer Bio receives Nasdaq minimum bid price deficiency notice, has until October 5, 2026](https://aibio.space/news/gossamer-bio-receives-nasdaq-minimum-bid-price-deficiency-notice-has/) |
| 2026-04-07 | Artelo Biosciences [ARTL](https://aibio.space/companies/artelo-biosciences/) | Regained compliance | [Artelo regains Nasdaq listing compliance, under one-year panel monitor](https://aibio.space/news/artelo-regains-nasdaq-listing-compliance-under-one-year-panel-monitor/) |
| 2026-04-03 | Matinas Biopharma Holdings [MTNB](https://aibio.space/companies/matinas-biopharma/) | Deficiency notice | [Matinas BioPharma receives NYSE American notice on three equity standards](https://aibio.space/news/matinas-biopharma-receives-nyse-american-notice-three-equity-standards/) |
| 2026-04-03 | AEON Biopharma [AEON](https://aibio.space/companies/aeon-biopharma/) | Deficiency notice | [AEON Biopharma receives additional NYSE American notice over stockholders' equity](https://aibio.space/news/aeon-biopharma-receives-additional-nyse-american-notice-stockholders/) |
| 2026-03-30 | InMed Pharmaceuticals [INM](https://aibio.space/companies/inmed-pharmaceuticals/) | Deficiency notice | [InMed Pharmaceuticals gets Nasdaq minimum bid price deficiency notice](https://aibio.space/news/inmed-pharmaceuticals-gets-nasdaq-minimum-bid-price-deficiency-notice/) |
| 2026-03-30 | Dyadic International [DYAI](https://aibio.space/companies/dyadic-international/) | Deficiency notice | [Dyadic International gets Nasdaq deficiency notice under Rule 5550(b) minimum listing requirements](https://aibio.space/news/dyadic-international-gets-nasdaq-deficiency-notice-under-rule-5550/) |
| 2026-03-30 | Kazia Therapeutics [KZIA](https://aibio.space/companies/kazia-therapeutics/) | Listing change | [Kazia reports AUD 69.46 million cash after US$46.51 million PIPE in half-year report](https://aibio.space/news/kazia-reports-aud-69-46-million-cash-after-us-46-51-million-pipe-half/) |
| 2026-03-30 | Zivo Bioscience [ZIVO](https://aibio.space/companies/zivo-bioscience/) | Delisting | [ZIVO Bioscience to delist from OTC markets and file Form 15 to end SEC reporting](https://aibio.space/news/zivo-bioscience-delist-otc-markets-file-form-15-end-sec-reporting/) |
| 2026-03-27 | Quantum Biopharma [QNTM](https://aibio.space/companies/quantum-biopharma/) | Listing change | [Quantum Biopharma reports 2025 results, believes cash lasts past January 2028](https://aibio.space/news/quantum-biopharma-reports-2025-results-believes-cash-lasts-past/) |
| 2026-03-25 | Zhengye Biotechnology Holding [ZYBT](https://aibio.space/companies/zhengye-biotechnology/) | Listing change | [Zhengye Biotechnology shareholders approve share reclassification and consolidation](https://aibio.space/news/zhengye-biotechnology-shareholders-approve-share-reclassification/) |
| 2026-03-20 | Ernexa Therapeutics [ERNA](https://aibio.space/companies/ernexa-therapeutics/) | Reverse split | [Ernexa Therapeutics gets Nasdaq minimum bid price notice, plans to request hearing](https://aibio.space/news/ernexa-therapeutics-gets-nasdaq-minimum-bid-price-notice-plans-request/) |
| 2026-03-20 | XTL Biopharmaceuticals [XTLB](https://aibio.space/companies/xtl-biopharmaceuticals/) | Listing change | [XTL Biopharmaceuticals to change ADS ratio to 400 ordinary shares on March 25, 2026](https://aibio.space/news/xtl-biopharmaceuticals-change-ads-ratio-400-ordinary-shares-march-25/) |
| 2026-03-19 | Skye Bioscience [SKYE](https://aibio.space/companies/skye-bioscience/) | Deficiency notice | [Skye Bioscience gets Nasdaq bid price deficiency notice, has until September 14, 2026](https://aibio.space/news/skye-bioscience-gets-nasdaq-bid-price-deficiency-notice-has-until/) |
| 2026-03-19 | Chemomab Therapeutics [CMMB](https://aibio.space/companies/chemomab-therapeutics/) | Listing change | [Chemomab reports 2025 results, cites FDA alignment and partner talks](https://aibio.space/news/chemomab-reports-2025-results-cites-fda-alignment-partner-talks/) |
| 2026-03-18 | Biodexa Pharmaceuticals [BDRX](https://aibio.space/companies/biodexa-pharmaceuticals/) | Listing change | [Biodexa to change ADR ratio to 500,000 shares, a one-for-five reverse ADR split](https://aibio.space/news/biodexa-change-adr-ratio-500-000-shares-one-five-reverse-adr-split/) |
| 2026-03-17 | Purple Biotech [PPBT](https://aibio.space/companies/purple-biotech/) | Regained compliance | [Purple Biotech regains Nasdaq minimum bid price compliance](https://aibio.space/news/purple-biotech-regains-nasdaq-minimum-bid-price-compliance/) |
| 2026-03-11 | Yarrow Bioscience [YARW](https://aibio.space/companies/yarrow-bioscience/) | Listing change | [VYNE Therapeutics (now Yarrow Bioscience) gets Nasdaq bid price extension to Sept. 7, 2026](https://aibio.space/news/vyne-therapeutics-now-yarrow-bioscience-gets-nasdaq-bid-price/) |
| 2026-03-09 | Longeveron [LGVN](https://aibio.space/companies/longeveron/) | Listing change | [Longeveron tells Nasdaq it lacks audit committee financial expert after director Kender resigns](https://aibio.space/news/longeveron-tells-nasdaq-lacks-audit-committee-financial-expert-after/) |
| 2026-03-02 | Anebulo Pharmaceuticals [ANEB](https://aibio.space/companies/anebulo-pharmaceuticals/) | Delisting | [Anebulo Pharmaceuticals files Form 15 to end SEC reporting duties](https://aibio.space/news/anebulo-pharmaceuticals-files-form-15-end-sec-reporting-duties/) |
| 2026-02-27 | Jupiter Neurosciences [JUNS](https://aibio.space/companies/jupiter-neurosciences/) | Deficiency notice | [Jupiter Neurosciences gets two Nasdaq notices on minimum bid price and market value](https://aibio.space/news/jupiter-neurosciences-gets-two-nasdaq-notices-minimum-bid-price-market/) |
| 2026-02-27 | Indaptus Therapeutics [INDP](https://aibio.space/companies/indaptus-therapeutics/) | Reverse split | [Indaptus stockholders approve preferred stock conversion and reverse split range](https://aibio.space/news/indaptus-stockholders-approve-preferred-stock-conversion-reverse-split/) |
| 2026-02-27 | Altamira Therapeutics [CYTOF](https://aibio.space/companies/altamira-therapeutics/) | Delisting | [Altamira Therapeutics files Form 15 to end SEC reporting duties](https://aibio.space/news/altamira-therapeutics-files-form-15-end-sec-reporting-duties/) |
| 2026-02-24 | Regentis Biomaterials [RGNT](https://aibio.space/companies/regentis-biomaterials/) | Listing change | [Regentis Biomaterials discloses going concern qualification in 2025 audit opinion](https://aibio.space/news/regentis-biomaterials-discloses-going-concern-qualification-2025-audit/) |
| 2026-02-19 | Psyence Biomedical [PBM](https://aibio.space/companies/psyence-biomedical/) | Listing change | [Psyence Biomedical shareholders approve share consolidation of up to 250:1](https://aibio.space/news/psyence-biomedical-shareholders-approve-share-consolidation-up-250-1/) |
| 2026-02-18 | Outlook Therapeutics [OTLK](https://aibio.space/companies/outlook-therapeutics/) | Deficiency notice | [Outlook Therapeutics gets Nasdaq minimum bid price deficiency notice, has until August 17, 2026](https://aibio.space/news/outlook-therapeutics-gets-nasdaq-minimum-bid-price-deficiency-notice/) |
| 2026-02-17 | Atossa Therapeutics [ATOS](https://aibio.space/companies/atossa-therapeutics/) | Regained compliance | [Atossa Therapeutics regains Nasdaq minimum bid price compliance](https://aibio.space/news/atossa-therapeutics-regains-nasdaq-minimum-bid-price-compliance/) |
| 2026-02-17 | Mereo BioPharma Group [MREO](https://aibio.space/companies/mereo-biopharma/) | Deficiency notice | [Mereo BioPharma gets Nasdaq minimum bid price deficiency notice on its ADSs](https://aibio.space/news/mereo-biopharma-gets-nasdaq-minimum-bid-price-deficiency-notice-adss/) |
| 2026-02-17 | Anebulo Pharmaceuticals [ANEB](https://aibio.space/companies/anebulo-pharmaceuticals/) | Delisting | [Anebulo Pharmaceuticals files Form 25 to withdraw its stock from Nasdaq](https://aibio.space/news/anebulo-pharmaceuticals-files-form-25-withdraw-stock-nasdaq/) |
| 2026-02-13 | Citius Pharmaceuticals [CTXR](https://aibio.space/companies/citius-pharmaceuticals/) | Deficiency notice | [Citius Pharmaceuticals gets Nasdaq minimum bid price notice; compliance deadline is August 10, 2026](https://aibio.space/news/citius-pharmaceuticals-gets-nasdaq-minimum-bid-price-notice-compliance/) |
| 2026-02-12 | Lunai Bioworks [LNAI](https://aibio.space/companies/lunai-bioworks/) | Reverse split | [Lunai Bioworks receives Nasdaq delisting determination over minimum bid price, requests hearing](https://aibio.space/news/lunai-bioworks-receives-nasdaq-delisting-determination-minimum-bid/) |
| 2026-02-06 | Vistagen Therapeutics [VTGN](https://aibio.space/companies/vistagen-therapeutics/) | Deficiency notice | [Vistagen gets Nasdaq minimum bid price deficiency notice, with until August 3, 2026 to comply](https://aibio.space/news/vistagen-gets-nasdaq-minimum-bid-price-deficiency-notice-until-august/) |
| 2026-02-06 | Anebulo Pharmaceuticals [ANEB](https://aibio.space/companies/anebulo-pharmaceuticals/) | Delisting | [Anebulo Pharmaceuticals to delist from Nasdaq and deregister with the SEC](https://aibio.space/news/anebulo-pharmaceuticals-delist-nasdaq-deregister-sec/) |
| 2026-02-02 | Polaryx Therapeutics [PLYX](https://aibio.space/companies/polaryx-therapeutics/) | New listing | [Polaryx begins Nasdaq trading through a direct listing](https://aibio.space/news/polaryx-begins-nasdaq-trading-through-direct-listing/) |
| 2026-01-30 | Tenaya Therapeutics [TNYA](https://aibio.space/companies/tenaya-therapeutics/) | Deficiency notice | [Tenaya Therapeutics gets Nasdaq minimum bid price notice, has until July 27, 2026](https://aibio.space/news/tenaya-therapeutics-gets-nasdaq-minimum-bid-price-notice-has-until/) |
| 2026-01-21 | UMeWorld [UMEW](https://aibio.space/companies/umeworld/) | New listing | [UMeWorld begins trading on OTC Markets as UMEW after move to Delaware](https://aibio.space/news/umeworld-begins-trading-otc-markets-umew-after-move-delaware/) |
| 2026-01-16 | GRI Bio [GRI](https://aibio.space/companies/gri-bio/) | Deficiency notice | [GRI Bio says Nasdaq found it conditionally regained stockholders' equity compliance](https://aibio.space/news/gri-bio-says-nasdaq-found-conditionally-regained-stockholders-equity/) |
| 2026-01-16 | NRX Pharmaceuticals [NRXP](https://aibio.space/companies/nrx-pharmaceuticals/) | Deficiency notice | [NRX Pharmaceuticals gets Nasdaq notice for missing annual meeting deadline](https://aibio.space/news/nrx-pharmaceuticals-gets-nasdaq-notice-missing-annual-meeting-deadline/) |
| 2026-01-12 | Polaryx Therapeutics [PLYX](https://aibio.space/companies/polaryx-therapeutics/) | Reverse split | [Polaryx completes one-for-four reverse stock split ahead of Nasdaq listing](https://aibio.space/news/polaryx-completes-one-four-reverse-stock-split-ahead-nasdaq-listing/) |
| 2026-01-07 | Propanc Biopharma [PPCB](https://aibio.space/companies/propanc-biopharma/) | Deficiency notice | [Propanc Biopharma gets Nasdaq minimum bid price deficiency notice, has until June 30, 2026](https://aibio.space/news/propanc-biopharma-gets-nasdaq-minimum-bid-price-deficiency-notice-has/) |
| 2026-01-06 | Immunic [IMUX](https://aibio.space/companies/immunic/) | Reverse split | [Immunic gets extra 180 days on Nasdaq bid price rule after transfer to Capital Market](https://aibio.space/news/immunic-gets-extra-180-days-nasdaq-bid-price-rule-after-transfer/) |
| 2026-01-02 | Decoy Therapeutics [DCOY](https://aibio.space/companies/decoy-therapeutics/) | Delisting | [Salarius Pharmaceuticals (now Decoy Therapeutics) gets Nasdaq delisting notice, will appeal](https://aibio.space/news/salarius-pharmaceuticals-now-decoy-therapeutics-gets-nasdaq-delisting-2/) |
| 2026-01-02 | FibroBiologics [FBLG](https://aibio.space/companies/fibrobiologics/) | Reverse split | [FibroBiologics gets Nasdaq delisting notice over bid price, plans to request a hearing](https://aibio.space/news/fibrobiologics-gets-nasdaq-delisting-notice-bid-price-plans-request/) |
| 2026-01-02 | Helus Pharma [HELP](https://aibio.space/companies/helus-pharma/) | Delisting | [Cybin Inc. (now Helus Pharma) files Form 25 to leave NYSE American](https://aibio.space/news/cybin-inc-now-helus-pharma-files-form-25-leave-nyse-american/) |
| 2026-01-02 | Northwest Biotherapeutics [NWBO](https://aibio.space/companies/northwest-biotherapeutics/) | Listing change | [Northwest Biotherapeutics holders approve raising authorized shares to 2,600,000,000](https://aibio.space/news/northwest-biotherapeutics-holders-approve-raising-authorized-shares-2/) |
| 2025-12-29 | Silo Pharma [SILO](https://aibio.space/companies/silo-pharma/) | Reverse split | [Silo Pharma gets second 180 days from Nasdaq to meet $1.00 minimum bid price](https://aibio.space/news/silo-pharma-gets-second-180-days-nasdaq-meet-1-00-minimum-bid-price/) |
| 2025-12-22 | Anebulo Pharmaceuticals [ANEB](https://aibio.space/companies/anebulo-pharmaceuticals/) | Reverse split | [Anebulo drops reverse split plan for $3.50-a-share self tender of up to 300,000 shares](https://aibio.space/news/anebulo-drops-reverse-split-plan-3-50-share-self-tender-up-300-000/) |
| 2025-12-22 | Apollomics [APLM](https://aibio.space/companies/apollomics/) | Listing change | [Apollomics interim report shows $4,398 thousand shareholders' deficit at June 30, 2025](https://aibio.space/news/apollomics-interim-report-shows-4-398-thousand-shareholders-deficit/) |
| 2025-12-17 | Azitra [AZTR](https://aibio.space/companies/azitra/) | Listing change | [NYSE American accepts Azitra's stockholders' equity compliance plan, sets April 1, 2027 deadline](https://aibio.space/news/nyse-american-accepts-azitras-stockholders-equity-compliance-plan-sets/) |
| 2025-12-16 | TherapeuticsMD [TXMD](https://aibio.space/companies/therapeuticsmd/) | Listing change | [TherapeuticsMD holders approve raising authorized common stock to 640,000,000 shares](https://aibio.space/news/therapeuticsmd-holders-approve-raising-authorized-common-stock-640-000/) |
| 2025-12-05 | PharmaCyte Biotech [PMCB](https://aibio.space/companies/pharmacyte-biotech/) | Reverse split | [PharmaCyte Biotech gets Nasdaq minimum bid price deficiency notice, has until June 1, 2026](https://aibio.space/news/pharmacyte-biotech-gets-nasdaq-minimum-bid-price-deficiency-notice-has/) |
| 2025-12-05 | Intensity Therapeutics [INTS](https://aibio.space/companies/intensity-therapeutics/) | Reverse split | [Intensity Therapeutics gets second 180 days to meet Nasdaq minimum bid price requirement](https://aibio.space/news/intensity-therapeutics-gets-second-180-days-meet-nasdaq-minimum-bid/) |
| 2025-12-05 | Polyrizon [PLRZ](https://aibio.space/companies/polyrizon/) | Listing change | [Polyrizon agrees to sell 552,269 shares at $9.00 in registered direct offering](https://aibio.space/news/polyrizon-agrees-sell-552-269-shares-9-00-registered-direct-offering/) |
| 2025-12-02 | GRI Bio [GRI](https://aibio.space/companies/gri-bio/) | Deficiency notice | [GRI Bio gets Nasdaq deficiency notice on minimum stockholders' equity requirement](https://aibio.space/news/gri-bio-gets-nasdaq-deficiency-notice-minimum-stockholders-equity/) |
| 2025-11-26 | GT Biopharma [GTBP](https://aibio.space/companies/gt-biopharma/) | Deficiency notice | [GT Biopharma gets Nasdaq minimum bid price notice, has until May 19, 2026 to regain compliance](https://aibio.space/news/gt-biopharma-gets-nasdaq-minimum-bid-price-notice-has-until-may-19/) |
| 2025-11-26 | Akari Therapeutics Plc [AKTX](https://aibio.space/companies/akari-therapeutics/) | Deficiency notice | [Akari Therapeutics gets Nasdaq minimum bid price deficiency notice, has until May 25, 2026](https://aibio.space/news/akari-therapeutics-gets-nasdaq-minimum-bid-price-deficiency-notice-has/) |
| 2025-11-26 | MetaVia [MTVA](https://aibio.space/companies/metavia/) | Reverse split | [MetaVia gets 180-day Nasdaq extension to May 26, 2026 on minimum bid price requirement](https://aibio.space/news/metavia-gets-180-day-nasdaq-extension-may-26-2026-minimum-bid-price/) |
| 2025-11-25 | Artelo Biosciences [ARTL](https://aibio.space/companies/artelo-biosciences/) | Delisting | [Artelo Biosciences gets Nasdaq delisting determination over stockholders' equity, plans appeal](https://aibio.space/news/artelo-biosciences-gets-nasdaq-delisting-determination-stockholders/) |
| 2025-11-21 | Moleculin Biotech [MBRX](https://aibio.space/companies/moleculin-biotech/) | Delisting | [Moleculin Biotech gets Nasdaq delisting determination, plans hearing panel appeal](https://aibio.space/news/moleculin-biotech-gets-nasdaq-delisting-determination-plans-hearing/) |
| 2025-11-18 | Soligenix [SNGX](https://aibio.space/companies/soligenix/) | Regained compliance | [Soligenix regains Nasdaq stockholders' equity compliance after August notice](https://aibio.space/news/soligenix-regains-nasdaq-stockholders-equity-compliance-after-august/) |
| 2025-11-17 | Shuttle Pharmaceuticals Holdings [SHPH](https://aibio.space/companies/shuttle-pharmaceuticals/) | Delisting | [Shuttle Pharmaceuticals believes $2.5 million private placement restored Nasdaq equity compliance](https://aibio.space/news/shuttle-pharmaceuticals-believes-2-5-million-private-placement/) |
| 2025-11-12 | COSCIENS Biopharma [CSCI](https://aibio.space/companies/cosciens-biopharma/) | Delisting | [COSCIENS Biopharma, delisted from Nasdaq in September, applies for OTCQB quotation](https://aibio.space/news/cosciens-biopharma-delisted-nasdaq-september-applies-otcqb-quotation/) |
| 2025-10-30 | Lunai Bioworks [LNAI](https://aibio.space/companies/lunai-bioworks/) | Deficiency notice | [Lunai Bioworks gets Nasdaq deficiency notice on $35 million market value requirement](https://aibio.space/news/lunai-bioworks-gets-nasdaq-deficiency-notice-35-million-market-value/) |
| 2025-10-23 | Enveric Biosciences [ENVB](https://aibio.space/companies/enveric-biosciences/) | Reverse split | [Enveric Biosciences gets Nasdaq delisting notice, sets 1-for-12 reverse split](https://aibio.space/news/enveric-biosciences-gets-nasdaq-delisting-notice-sets-1-12-reverse/) |
| 2025-10-21 | Oragenics [OGEN](https://aibio.space/companies/oragenics/) | Regained compliance | [Oragenics regains NYSE American equity compliance, settles Ladenburg fee claim for $700,000](https://aibio.space/news/oragenics-regains-nyse-american-equity-compliance-settles-ladenburg/) |
| 2025-10-17 | Aspire-Lakewood Holdings [ASBP](https://aibio.space/companies/aspire-lakewood/) | Delisting | [Aspire Biopharma Holdings (now Aspire-Lakewood Holdings) seeks Nasdaq hearing on delisting](https://aibio.space/news/aspire-biopharma-holdings-now-aspire-lakewood-holdings-seeks-nasdaq/) |
| 2025-10-16 | HCW Biologics [HCWB](https://aibio.space/companies/hcw-biologics/) | Deficiency notice | [HCW Biologics wins Nasdaq panel extension to meet equity rule by December 31, 2025](https://aibio.space/news/hcw-biologics-wins-nasdaq-panel-extension-meet-equity-rule-december-31/) |
| 2025-10-16 | Kura Oncology [KURA](https://aibio.space/companies/kura-oncology/) | Listing change | [Kura Oncology files amended 2023 Inducement Option Plan with 3,250,000-share reserve](https://aibio.space/news/kura-oncology-files-amended-2023-inducement-option-plan-3-250-000/) |
| 2025-10-07 | Adicet Bio [ACET](https://aibio.space/companies/adicet-bio/) | Listing change | [Adicet Bio gets until April 6, 2026 to meet Nasdaq bid price rule, moves listing](https://aibio.space/news/adicet-bio-gets-until-april-6-2026-meet-nasdaq-bid-price-rule-moves/) |
| 2025-10-06 | Decoy Therapeutics [DCOY](https://aibio.space/companies/decoy-therapeutics/) | Listing change | [Salarius (now Decoy Therapeutics) says share sales lift equity above Nasdaq minimum](https://aibio.space/news/salarius-now-decoy-therapeutics-says-share-sales-lift-equity-above/) |
| 2025-10-06 | Werewolf Therapeutics [HOWL](https://aibio.space/companies/werewolf-therapeutics/) | Listing change | [Werewolf Therapeutics breaks Nasdaq audit committee rule after director dies](https://aibio.space/news/werewolf-therapeutics-breaks-nasdaq-audit-committee-rule-after/) |
| 2025-10-06 | ZyVersa Therapeutics [ZVSA](https://aibio.space/companies/zyversa-therapeutics/) | Delisting | [Nasdaq files Form 25 to delist ZyVersa Therapeutics common stock](https://aibio.space/news/nasdaq-files-form-25-delist-zyversa-therapeutics-common-stock/) |
| 2025-10-03 | Xilio Therapeutics [XLO](https://aibio.space/companies/xilio-therapeutics/) | Listing change | [Xilio Therapeutics moves to Nasdaq Capital Market, gets until March 30, 2026 on bid price](https://aibio.space/news/xilio-therapeutics-moves-nasdaq-capital-market-gets-until-march-30/) |
| 2025-10-03 | Azitra [AZTR](https://aibio.space/companies/azitra/) | Deficiency notice | [Azitra gets NYSE American notice over minimum stockholders' equity requirement](https://aibio.space/news/azitra-gets-nyse-american-notice-minimum-stockholders-equity/) |
| 2025-10-03 | Abpro Holdings [ABPO](https://aibio.space/companies/abpro/) | Delisting | [Abpro Holdings faces Nasdaq delisting after missing $1.00 bid price deadline](https://aibio.space/news/abpro-holdings-faces-nasdaq-delisting-after-missing-1-00-bid-price/) |
| 2025-10-03 | Azitra [AZTR](https://aibio.space/companies/azitra/) | Deficiency notice | [Azitra gets NYSE American notice over $4 million stockholders' equity standard](https://aibio.space/news/azitra-gets-nyse-american-notice-4-million-stockholders-equity/) |
| 2025-10-03 | Xilio Therapeutics [XLO](https://aibio.space/companies/xilio-therapeutics/) | Listing change | [Xilio Therapeutics moves to Nasdaq Capital Market, gets 180 more days on $1.00 bid rule](https://aibio.space/news/xilio-therapeutics-moves-nasdaq-capital-market-gets-180-more-days-1-00/) |
| 2025-10-02 | BioCardia [BCDA](https://aibio.space/companies/biocardia/) | Regained compliance | [BioCardia regains compliance with Nasdaq equity rule](https://aibio.space/news/biocardia-regains-compliance-nasdaq-equity-rule/) |
| 2025-09-29 | Bon Natural Life [BON](https://aibio.space/companies/bon-natural-life/) | Listing change | [Bon Natural Life's interim results reflect 1-for-25 share consolidation and offering](https://aibio.space/news/bon-natural-lifes-interim-results-reflect-1-25-share-consolidation/) |
| 2025-09-29 | Estrella Immunopharma [ESLA](https://aibio.space/companies/estrella-immunopharma/) | Regained compliance | [Estrella Immunopharma regains Nasdaq compliance on bid price and market value rules](https://aibio.space/news/estrella-immunopharma-regains-nasdaq-compliance-bid-price-market-value/) |
| 2025-09-26 | Tevogen [TVGN](https://aibio.space/companies/tevogen/) | Deficiency notice | [Tevogen Bio Holdings Inc. (now Tevogen Inc.) gets Nasdaq minimum bid price notice](https://aibio.space/news/tevogen-bio-holdings-inc-now-tevogen-inc-gets-nasdaq-minimum-bid-price/) |
| 2025-09-26 | Longeveron [LGVN](https://aibio.space/companies/longeveron/) | Delisting | [Longeveron gets Nasdaq minimum bid price notice, has until March 23, 2026 to regain compliance](https://aibio.space/news/longeveron-gets-nasdaq-minimum-bid-price-notice-has-until-march-23/) |
| 2025-09-26 | Adaptimmune Therapeutics [ADAPY](https://aibio.space/companies/adaptimmune-therapeutics/) | Delisting | [Adaptimmune gets Nasdaq panel exception until December 1, 2025, to fix bid price](https://aibio.space/news/adaptimmune-gets-nasdaq-panel-exception-until-december-1-2025-fix-bid/) |
| 2025-09-26 | Longeveron [LGVN](https://aibio.space/companies/longeveron/) | Deficiency notice | [Longeveron gets Nasdaq notice for trading below the $1.00 minimum bid price](https://aibio.space/news/longeveron-gets-nasdaq-notice-trading-below-1-00-minimum-bid-price/) |
| 2025-09-25 | Silexion Therapeutics [SLXN](https://aibio.space/companies/silexion-therapeutics/) | Regained compliance | [Silexion Therapeutics regains Nasdaq equity and bid-price compliance](https://aibio.space/news/silexion-therapeutics-regains-nasdaq-equity-bid-price-compliance/) |
| 2025-09-24 | BioCardia [BCDA](https://aibio.space/companies/biocardia/) | Listing change | [BioCardia believes it regained Nasdaq stockholders' equity compliance after stock sales](https://aibio.space/news/biocardia-believes-regained-nasdaq-stockholders-equity-compliance/) |
| 2025-09-22 | BioAtla [BCAB](https://aibio.space/companies/bioatla/) | Deficiency notice | [BioAtla wins Nasdaq panel extension with deadlines to fix price and equity gaps](https://aibio.space/news/bioatla-wins-nasdaq-panel-extension-deadlines-fix-price-equity-gaps/) |
| 2025-09-19 | Prelude Therapeutics [PRLD](https://aibio.space/companies/prelude-therapeutics/) | Regained compliance | [Prelude Therapeutics regains compliance with Nasdaq $1.00 minimum bid price rule](https://aibio.space/news/prelude-therapeutics-regains-compliance-nasdaq-1-00-minimum-bid-price/) |
| 2025-09-19 | Vaxart [VXRT](https://aibio.space/companies/vaxart/) | Reverse split | [Vaxart to be delisted from Nasdaq after missing hearings panel conditions](https://aibio.space/news/vaxart-delisted-nasdaq-after-missing-hearings-panel-conditions/) |
| 2025-09-18 | ZyVersa Therapeutics [ZVSA](https://aibio.space/companies/zyversa-therapeutics/) | Delisting | [Nasdaq to complete delisting of ZyVersa Therapeutics stock with Form 25 filing](https://aibio.space/news/nasdaq-complete-delisting-zyversa-therapeutics-stock-form-25-filing/) |
| 2025-09-17 | AquaBounty Technologies [AQB](https://aibio.space/companies/aquabounty-technologies/) | Regained compliance | [AquaBounty regains compliance with Nasdaq $1.00 minimum bid price rule](https://aibio.space/news/aquabounty-regains-compliance-nasdaq-1-00-minimum-bid-price-rule/) |
| 2025-09-16 | Neuphoria Therapeutics [NEUP](https://aibio.space/companies/neuphoria-therapeutics/) | Deficiency notice | [Neuphoria Therapeutics gets Nasdaq extension to December 29, 2025 to hold annual meeting](https://aibio.space/news/neuphoria-therapeutics-gets-nasdaq-extension-december-29-2025-hold/) |
| 2025-09-16 | Bio Green Med Solution [BGMS](https://aibio.space/companies/bio-green-med-solution/) | Listing change | [Bio Green Med Solution preferred stock falls short of Nasdaq $1 million value rule](https://aibio.space/news/bio-green-med-solution-preferred-stock-falls-short-nasdaq-1-million/) |
| 2025-09-16 | Ovid Therapeutics [OVID](https://aibio.space/companies/ovid-therapeutics/) | Regained compliance | [Ovid Therapeutics regains compliance with Nasdaq $1.00 bid price rule](https://aibio.space/news/ovid-therapeutics-regains-compliance-nasdaq-1-00-bid-price-rule/) |
| 2025-09-16 | Relmada Therapeutics [RLMD](https://aibio.space/companies/relmada-therapeutics/) | Regained compliance | [Relmada Therapeutics regains compliance with Nasdaq $1.00 bid price rule](https://aibio.space/news/relmada-therapeutics-regains-compliance-nasdaq-1-00-bid-price-rule/) |
| 2025-09-12 | Yarrow Bioscience [YARW](https://aibio.space/companies/yarrow-bioscience/) | Deficiency notice | [VYNE Therapeutics (now Yarrow Bioscience) gets Nasdaq minimum bid price notice](https://aibio.space/news/vyne-therapeutics-now-yarrow-bioscience-gets-nasdaq-minimum-bid-price/) |
| 2025-09-12 | Pluri [PLUR](https://aibio.space/companies/pluri/) | Regained compliance | [Pluri regains Nasdaq audit committee compliance after naming independent director](https://aibio.space/news/pluri-regains-nasdaq-audit-committee-compliance-after-naming/) |
| 2025-09-12 | Yarrow Bioscience [YARW](https://aibio.space/companies/yarrow-bioscience/) | Deficiency notice | [VYNE Therapeutics (now Yarrow Bioscience) gets Nasdaq notice for sub-$1.00 stock](https://aibio.space/news/vyne-therapeutics-now-yarrow-bioscience-gets-nasdaq-notice-sub-1-00/) |
| 2025-09-09 | OSR Health [OSRH](https://aibio.space/companies/osr-health/) | Deficiency notice | [OSR Holdings (now OSR Health) gets Nasdaq notice after 30 days below $1.00](https://aibio.space/news/osr-holdings-now-osr-health-gets-nasdaq-notice-after-30-days-below-1/) |
| 2025-09-08 | Coherus Oncology [CHRS](https://aibio.space/companies/coherus-oncology/) | Regained compliance | [Coherus Oncology regains Nasdaq compliance with $1.00 minimum bid price rule](https://aibio.space/news/coherus-oncology-regains-nasdaq-compliance-1-00-minimum-bid-price-rule/) |
| 2025-09-05 | NuCana [NCNA](https://aibio.space/companies/nucana/) | Listing change | [NuCana says Nasdaq confirmed compliance and closed its listing matter](https://aibio.space/news/nucana-says-nasdaq-confirmed-compliance-closed-listing-matter/) |
| 2025-09-04 | CERo Therapeutics Holdings [CERO](https://aibio.space/companies/cero-therapeutics/) | Delisting | [CERo Therapeutics appeals Nasdaq delisting over $2,500,000 stockholders' equity rule](https://aibio.space/news/cero-therapeutics-appeals-nasdaq-delisting-2-500-000-stockholders/) |
| 2025-09-04 | Equillium [EQ](https://aibio.space/companies/equillium/) | Regained compliance | [Equillium regains compliance with Nasdaq's $1.00 minimum bid price rule](https://aibio.space/news/equillium-regains-compliance-nasdaqs-1-00-minimum-bid-price-rule/) |
| 2025-09-04 | Mesoblast [MSB](https://aibio.space/companies/mesoblast/) | Listing change | [Mesoblast signs option to issue up to US$50 million of convertible notes](https://aibio.space/news/mesoblast-signs-option-issue-up-us-50-million-convertible-notes/) |
| 2025-09-03 | Adial Pharmaceuticals [ADIL](https://aibio.space/companies/adial-pharmaceuticals/) | Listing change | [Adial Pharmaceuticals gets 180-day Nasdaq extension on $1.00 bid price rule](https://aibio.space/news/adial-pharmaceuticals-gets-180-day-nasdaq-extension-1-00-bid-price/) |
| 2025-09-03 | Celularity [CELU](https://aibio.space/companies/celularity/) | Regained compliance | [Celularity regains Nasdaq compliance after filing two late quarterly reports](https://aibio.space/news/celularity-regains-nasdaq-compliance-after-filing-two-late-quarterly/) |
| 2025-09-03 | Ironwood Pharmaceuticals [IRWD](https://aibio.space/companies/ironwood-pharmaceuticals/) | Regained compliance | [Ironwood Pharmaceuticals regains compliance with Nasdaq $1.00 bid price rule](https://aibio.space/news/ironwood-pharmaceuticals-regains-compliance-nasdaq-1-00-bid-price-rule/) |
| 2025-09-02 | Context Therapeutics [CNTX](https://aibio.space/companies/context-therapeutics/) | Reverse split | [Context Therapeutics gets Nasdaq extension to February 23, 2026 on minimum bid price rule](https://aibio.space/news/context-therapeutics-gets-nasdaq-extension-february-23-2026-minimum/) |
| 2025-09-02 | Context Therapeutics [CNTX](https://aibio.space/companies/context-therapeutics/) | Reverse split | [Context Therapeutics gets 180 more days from Nasdaq to meet $1.00 bid price rule](https://aibio.space/news/context-therapeutics-gets-180-more-days-nasdaq-meet-1-00-bid-price/) |
| 2025-08-29 | Envoy Medical [COCH](https://aibio.space/companies/envoy-medical/) | Delisting | [Envoy Medical asks Nasdaq panel to review delisting determination on market value rule](https://aibio.space/news/envoy-medical-asks-nasdaq-panel-review-delisting-determination-market/) |
| 2025-08-29 | Enveric Biosciences [ENVB](https://aibio.space/companies/enveric-biosciences/) | Deficiency notice | [Enveric Biosciences gets Nasdaq stockholders' equity deficiency notice, plan due October 10, 2025](https://aibio.space/news/enveric-biosciences-gets-nasdaq-stockholders-equity-deficiency-notice/) |
| 2025-08-29 | Enveric Biosciences [ENVB](https://aibio.space/companies/enveric-biosciences/) | Deficiency notice | [Enveric Biosciences falls short of Nasdaq $2,500,000 stockholders' equity rule](https://aibio.space/news/enveric-biosciences-falls-short-nasdaq-2-500-000-stockholders-equity/) |
| 2025-08-29 | Century Therapeutics [IPSC](https://aibio.space/companies/century-therapeutics/) | Listing change | [Century Therapeutics gets 180 more days to meet Nasdaq bid price rule](https://aibio.space/news/century-therapeutics-gets-180-more-days-meet-nasdaq-bid-price-rule/) |
| 2025-08-29 | Rallybio [RLYB](https://aibio.space/companies/rallybio/) | Listing change | [Rallybio moves to Nasdaq Capital Market, gets 180 more days on bid price](https://aibio.space/news/rallybio-moves-nasdaq-capital-market-gets-180-more-days-bid-price/) |
| 2025-08-28 | Xilio Therapeutics [XLO](https://aibio.space/companies/xilio-therapeutics/) | Deficiency notice | [Xilio Therapeutics gets Nasdaq notice over stockholders' equity below $10.0 million](https://aibio.space/news/xilio-therapeutics-gets-nasdaq-notice-stockholders-equity-below-10-0/) |
| 2025-08-28 | Imunon [IMNN](https://aibio.space/companies/imunon/) | Regained compliance | [Imunon regains compliance with Nasdaq minimum bid price requirement](https://aibio.space/news/imunon-regains-compliance-nasdaq-minimum-bid-price-requirement/) |
| 2025-08-28 | Imunon [IMNN](https://aibio.space/companies/imunon/) | Regained compliance | [Imunon regains Nasdaq minimum bid price compliance after hearings panel confirmation](https://aibio.space/news/imunon-regains-nasdaq-minimum-bid-price-compliance-after-hearings/) |
| 2025-08-27 | Veru [VERU](https://aibio.space/companies/veru/) | Regained compliance | [Veru regains compliance with Nasdaq minimum bid price rule](https://aibio.space/news/veru-regains-compliance-nasdaq-minimum-bid-price-rule/) |
| 2025-08-26 | BriaCell Therapeutics, BriaCell Therapeutics [BCT](https://aibio.space/companies/briacell-therapeutics/)[BCTX](https://aibio.space/companies/briacell-therapeutics-bctx/) | Listing change | [BriaCell plans 1-for-10 share consolidation to meet Nasdaq listing rules](https://aibio.space/news/briacell-plans-1-10-share-consolidation-meet-nasdaq-listing-rules/) |
| 2025-08-26 | Cognition Therapeutics [CGTX](https://aibio.space/companies/cognition-therapeutics/) | Regained compliance | [Cognition Therapeutics regains compliance with Nasdaq $1.00 bid price rule](https://aibio.space/news/cognition-therapeutics-regains-compliance-nasdaq-1-00-bid-price-rule/) |
| 2025-08-26 | Cerenome [CNSY](https://aibio.space/companies/cerenome/) | Listing change | [Plus Therapeutics (now Cerenome) wins Nasdaq equity nod, more time on $1.00 bid rule](https://aibio.space/news/plus-therapeutics-now-cerenome-wins-nasdaq-equity-nod-more-time-1-00/) |
| 2025-08-26 | COSCIENS Biopharma [CSCI](https://aibio.space/companies/cosciens-biopharma/) | Delisting | [COSCIENS Biopharma files Form 25 to withdraw its shares from Nasdaq](https://aibio.space/news/cosciens-biopharma-files-form-25-withdraw-shares-nasdaq/) |
| 2025-08-25 | Liminatus Pharma [LIMN](https://aibio.space/companies/liminatus-pharma/) | Deficiency notice | [Liminatus Pharma gets Nasdaq deficiency notice over late Form 10-Q](https://aibio.space/news/liminatus-pharma-gets-nasdaq-deficiency-notice-late-form-10/) |
| 2025-08-25 | Dermata Therapeutics [DRMA](https://aibio.space/companies/dermata-therapeutics/) | Regained compliance | [Dermata Therapeutics regains Nasdaq compliance after hearing panel exception](https://aibio.space/news/dermata-therapeutics-regains-nasdaq-compliance-after-hearing-panel/) |
| 2025-08-22 | Curis [CRIS](https://aibio.space/companies/curis/) | Delisting | [Curis gets Nasdaq delisting determination over market value rule, plans to appeal](https://aibio.space/news/curis-gets-nasdaq-delisting-determination-market-value-rule-plans/) |
| 2025-08-22 | Curis [CRIS](https://aibio.space/companies/curis/) | Delisting | [Curis to appeal Nasdaq delisting after missing $35,000,000 market value rule](https://aibio.space/news/curis-appeal-nasdaq-delisting-after-missing-35-000-000-market-value/) |
| 2025-08-21 | Atossa Therapeutics [ATOS](https://aibio.space/companies/atossa-therapeutics/) | Reverse split | [Atossa Therapeutics gets 180 more days to meet Nasdaq $1.00 bid price rule](https://aibio.space/news/atossa-therapeutics-gets-180-more-days-meet-nasdaq-1-00-bid-price-rule/) |
| 2025-08-20 | Genprex [GNPX](https://aibio.space/companies/genprex/) | Delisting | [Genprex gets second Nasdaq delisting basis over stockholders' equity, requests hearing](https://aibio.space/news/genprex-gets-second-nasdaq-delisting-basis-stockholders-equity/) |
| 2025-08-20 | Windtree Therapeutics [WINT](https://aibio.space/companies/windtree-therapeutics/) | Delisting | [Windtree Therapeutics to be delisted by Nasdaq, shares move to OTC market](https://aibio.space/news/windtree-therapeutics-delisted-nasdaq-shares-move-otc-market/) |
| 2025-08-19 | HCW Biologics [HCWB](https://aibio.space/companies/hcw-biologics/) | Listing change | [HCW Biologics faces Nasdaq suspension over equity rule and plans to request a hearing](https://aibio.space/news/hcw-biologics-faces-nasdaq-suspension-equity-rule-plans-request/) |
| 2025-08-18 | Genprex [GNPX](https://aibio.space/companies/genprex/) | Delisting | [Genprex gets second Nasdaq deficiency notice, with equity at $1,391,195](https://aibio.space/news/genprex-gets-second-nasdaq-deficiency-notice-equity-1-391-195/) |
| 2025-08-15 | Sol-Gel Technologies [SLGL](https://aibio.space/companies/sol-gel-technologies/) | Listing change | [Sol-Gel reports $24.2 million in cash, expects runway into early 2027](https://aibio.space/news/sol-gel-reports-24-2-million-cash-expects-runway-early-2027/) |
| 2025-08-15 | Soligenix [SNGX](https://aibio.space/companies/soligenix/) | Deficiency notice | [Soligenix gets Nasdaq notice for stockholders' equity below $2,500,000](https://aibio.space/news/soligenix-gets-nasdaq-notice-stockholders-equity-below-2-500-000/) |
| 2025-08-12 | Intensity Therapeutics [INTS](https://aibio.space/companies/intensity-therapeutics/) | Regained compliance | [Intensity Therapeutics regains Nasdaq stockholders' equity compliance](https://aibio.space/news/intensity-therapeutics-regains-nasdaq-stockholders-equity-compliance/) |
| 2025-08-12 | Veru [VERU](https://aibio.space/companies/veru/) | Reverse split | [Veru completes 1-for-10 reverse stock split on Nasdaq](https://aibio.space/news/veru-completes-1-10-reverse-stock-split-nasdaq/) |
| 2025-08-12 | Verrica Pharmaceuticals [VRCA](https://aibio.space/companies/verrica-pharmaceuticals/) | Reverse split | [Verrica Pharmaceuticals details 1-for-10 reverse split and $8.0 million Torii milestone](https://aibio.space/news/verrica-pharmaceuticals-details-1-10-reverse-split-8-0-million-torii/) |
| 2025-08-08 | FibroBiologics [FBLG](https://aibio.space/companies/fibrobiologics/) | Deficiency notice | [FibroBiologics gets Nasdaq notice for market value below $35.0 million](https://aibio.space/news/fibrobiologics-gets-nasdaq-notice-market-value-below-35-0-million/) |
| 2025-08-08 | Processa Pharmaceuticals [PCSA](https://aibio.space/companies/processa-pharmaceuticals/) | Reverse split | [Processa Pharmaceuticals gets second 180-day Nasdaq period to fix bid price](https://aibio.space/news/processa-pharmaceuticals-gets-second-180-day-nasdaq-period-fix-bid/) |
| 2025-08-07 | Estrella Immunopharma [ESLA](https://aibio.space/companies/estrella-immunopharma/) | Deficiency notice | [Estrella Immunopharma gets Nasdaq deficiency notice on $35,000,000 market value requirement](https://aibio.space/news/estrella-immunopharma-gets-nasdaq-deficiency-notice-35-000-000-market/) |
| 2025-08-05 | Bon Natural Life [BON](https://aibio.space/companies/bon-natural-life/) | Deficiency notice | [Bon Natural Life says Nasdaq closed bid price matter, with one-year panel monitor](https://aibio.space/news/bon-natural-life-says-nasdaq-closed-bid-price-matter-one-year-panel/) |
| 2025-08-05 | Ocean Biomediacal [OCEA](https://aibio.space/companies/ocean-biomediacal/) | Delisting | [Ocean Biomedical's Nasdaq delisting becomes final after board declines review](https://aibio.space/news/ocean-biomedicals-nasdaq-delisting-becomes-final-after-board-declines/) |
| 2025-08-04 | Exicure [XCUR](https://aibio.space/companies/exicure/) | Regained compliance | [Exicure regains compliance with Nasdaq periodic filing rule](https://aibio.space/news/exicure-regains-compliance-nasdaq-periodic-filing-rule/) |
| 2025-08-01 | GeoVax Labs [GOVX](https://aibio.space/companies/geovax-labs/) | Deficiency notice | [GeoVax receives Nasdaq bid price deficiency notice, has until January 27, 2026](https://aibio.space/news/geovax-receives-nasdaq-bid-price-deficiency-notice-has-until-january/) |
| 2025-08-01 | iBio [IBIO](https://aibio.space/companies/ibio/) | Deficiency notice | [iBio receives Nasdaq notice for trading below $1.00 minimum bid price](https://aibio.space/news/ibio-receives-nasdaq-notice-trading-below-1-00-minimum-bid-price/) |
| 2025-07-30 | AIM ImmunoTech [AIM](https://aibio.space/companies/aim-immunotech/) | Reverse split | [AIM ImmunoTech prices $8.0 million unit offering as it works to fix equity shortfall](https://aibio.space/news/aim-immunotech-prices-8-0-million-unit-offering-works-fix-equity/) |
| 2025-07-29 | Endovia Health Sciences [EDVA](https://aibio.space/companies/endovia-health-sciences/) | Delisting | [Splash Beverage Group (now Endovia Health Sciences) faces NYSE American warrant delisting](https://aibio.space/news/splash-beverage-group-now-endovia-health-sciences-faces-nyse-american/) |
| 2025-07-29 | MindWalk Holdings [HYFT](https://aibio.space/companies/mindwalk/) | Listing change | [ImmunoPrecise Antibodies (now MindWalk Holdings) reports fiscal 2025 results](https://aibio.space/news/immunoprecise-antibodies-now-mindwalk-holdings-reports-fiscal-2025/) |
| 2025-07-29 | Ocugen [OCGN](https://aibio.space/companies/ocugen/) | Regained compliance | [Ocugen regains compliance with Nasdaq $1.00 minimum bid price rule](https://aibio.space/news/ocugen-regains-compliance-nasdaq-1-00-minimum-bid-price-rule/) |
| 2025-07-29 | Passage Bio [PASG](https://aibio.space/companies/passage-bio/) | Regained compliance | [Passage Bio regains compliance with Nasdaq minimum bid price rule](https://aibio.space/news/passage-bio-regains-compliance-nasdaq-minimum-bid-price-rule/) |
| 2025-07-24 | Advanced Biomed [ADVB](https://aibio.space/companies/advanced-biomed/) | Deficiency notice | [Advanced Biomed gets Nasdaq bid price notice, has until January 14, 2026 to comply](https://aibio.space/news/advanced-biomed-gets-nasdaq-bid-price-notice-has-until-january-14-2026/) |
| 2025-07-18 | Neuphoria Therapeutics [NEUP](https://aibio.space/companies/neuphoria-therapeutics/) | Deficiency notice | [Neuphoria Therapeutics gets Nasdaq notice over annual meeting requirement](https://aibio.space/news/neuphoria-therapeutics-gets-nasdaq-notice-annual-meeting-requirement/) |
| 2025-07-18 | Avenue Therapeutics [ATXI](https://aibio.space/companies/avenue-therapeutics/) | Delisting | [Nasdaq files Form 25 to delist Avenue Therapeutics common stock](https://aibio.space/news/nasdaq-files-form-25-delist-avenue-therapeutics-common-stock/) |
| 2025-07-17 | Connect Biopharma Holdings [CNTB](https://aibio.space/companies/connect-biopharma/) | Regained compliance | [Connect Biopharma regains compliance with Nasdaq $1.00 minimum bid price rule](https://aibio.space/news/connect-biopharma-regains-compliance-nasdaq-1-00-minimum-bid-price/) |
| 2025-07-16 | Cell Source [CLCS](https://aibio.space/companies/cell-source/) | Delisting | [Cell Source keeps filing delayed reports after its July 2025 Form 15 notice](https://aibio.space/news/cell-source-keeps-filing-delayed-reports-after-july-2025-form-15/) |
| 2025-07-16 | Indaptus Therapeutics [INDP](https://aibio.space/companies/indaptus-therapeutics/) | Regained compliance | [Indaptus Therapeutics regains Nasdaq compliance with $1.00 bid price rule](https://aibio.space/news/indaptus-therapeutics-regains-nasdaq-compliance-1-00-bid-price-rule/) |
| 2025-07-14 | Imunon [IMNN](https://aibio.space/companies/imunon/) | Delisting | [Imunon gets Nasdaq Hearing Panel exception after delisting determination](https://aibio.space/news/imunon-gets-nasdaq-hearing-panel-exception-after-delisting/) |
| 2025-07-11 | Bio-Path Holdings [BPTH](https://aibio.space/companies/bio-path/) | Delisting | [Nasdaq files Form 25 to remove Bio-Path Holdings common stock from listing](https://aibio.space/news/nasdaq-files-form-25-remove-bio-path-holdings-common-stock-listing/) |
| 2025-07-10 | Jupiter Neurosciences [JUNS](https://aibio.space/companies/jupiter-neurosciences/) | Regained compliance | [Jupiter Neurosciences regains compliance with Nasdaq $1.00 minimum bid price rule](https://aibio.space/news/jupiter-neurosciences-regains-compliance-nasdaq-1-00-minimum-bid-price/) |
| 2025-07-10 | Vor Biopharma [VOR](https://aibio.space/companies/vor-biopharma/) | Listing change | [Vor Bio names Sandy Mahatme CFO and grants 13,882,750 inducement RSUs](https://aibio.space/news/vor-bio-names-sandy-mahatme-cfo-grants-13-882-750-inducement-rsus/) |
| 2025-07-09 | Faeth Therapeutics [FTH](https://aibio.space/companies/faeth-therapeutics/) | Regained compliance | [Sensei Biotherapeutics (now Faeth Therapeutics) regains Nasdaq bid price compliance](https://aibio.space/news/sensei-biotherapeutics-now-faeth-therapeutics-regains-nasdaq-bid-price/) |
| 2025-07-08 | GridAI Technologies [GRDX](https://aibio.space/companies/gridai-technologies/) | Regained compliance | [Entero Therapeutics (now GridAI Technologies) regains Nasdaq annual meeting compliance](https://aibio.space/news/entero-therapeutics-now-gridai-technologies-regains-nasdaq-annual/) |
| 2025-07-08 | Unicycive Therapeutics [UNCY](https://aibio.space/companies/unicycive-therapeutics/) | Reverse split | [Unicycive regains Nasdaq minimum bid price compliance after reverse split](https://aibio.space/news/unicycive-regains-nasdaq-minimum-bid-price-compliance-after-reverse/) |
| 2025-07-07 | ProMIS Neurosciences [PMN](https://aibio.space/companies/promis-neurosciences/) | Reverse split | [ProMIS Neurosciences gets second 180-day period to meet Nasdaq bid price rule](https://aibio.space/news/promis-neurosciences-gets-second-180-day-period-meet-nasdaq-bid-price/) |
| 2025-07-03 | Coherus Oncology [CHRS](https://aibio.space/companies/coherus-oncology/) | Deficiency notice | [Coherus Oncology gets Nasdaq minimum bid price deficiency notice, has until December 29, 2025](https://aibio.space/news/coherus-oncology-gets-nasdaq-minimum-bid-price-deficiency-notice-has/) |
| 2025-07-03 | Pluri [PLUR](https://aibio.space/companies/pluri/) | Deficiency notice | [Pluri gets Nasdaq audit committee notice after director Doron Birger is not re-elected](https://aibio.space/news/pluri-gets-nasdaq-audit-committee-notice-after-director-doron-birger/) |
| 2025-07-03 | Silo Pharma [SILO](https://aibio.space/companies/silo-pharma/) | Reverse split | [Silo Pharma gets Nasdaq minimum bid price notice, has until December 24, 2025 to regain compliance](https://aibio.space/news/silo-pharma-gets-nasdaq-minimum-bid-price-notice-has-until-december-24/) |
| 2025-07-03 | Lexicon Pharmaceuticals [LXRX](https://aibio.space/companies/lexicon-pharmaceuticals/) | Reverse split | [Lexicon Pharmaceuticals moves to Nasdaq Capital Market to get more time on $1 bid rule](https://aibio.space/news/lexicon-pharmaceuticals-moves-nasdaq-capital-market-get-more-time-1/) |
| 2025-07-03 | Silo Pharma [SILO](https://aibio.space/companies/silo-pharma/) | Reverse split | [Silo Pharma gets Nasdaq bid price notice, has until December 24, 2025](https://aibio.space/news/silo-pharma-gets-nasdaq-bid-price-notice-has-until-december-24-2025/) |
| 2025-07-02 | Pelthos Therapeutics [PTHS](https://aibio.space/companies/pelthos-therapeutics/) | Reverse split | [Channel Therapeutics (now Pelthos Therapeutics) closes merger and $50.1 million private placement](https://aibio.space/news/channel-therapeutics-now-pelthos-therapeutics-closes-merger-50-1/) |
| 2025-07-02 | Alaunos Therapeutics [TCRT](https://aibio.space/companies/alaunos-therapeutics/) | Listing change | [Alaunos Therapeutics tells Nasdaq it falls short of audit committee rule after CEO change](https://aibio.space/news/alaunos-therapeutics-tells-nasdaq-falls-short-audit-committee-rule/) |
| 2025-07-02 | Pelthos Therapeutics [PTHS](https://aibio.space/companies/pelthos-therapeutics/) | Reverse split | [Channel Therapeutics (now Pelthos) sets 10-for-one reverse split ahead of merger](https://aibio.space/news/channel-therapeutics-now-pelthos-sets-10-one-reverse-split-ahead/) |
| 2025-07-01 | Ocugen [OCGN](https://aibio.space/companies/ocugen/) | Listing change | [Ocugen gets 180 more days from Nasdaq to meet minimum bid price, until December 29, 2025](https://aibio.space/news/ocugen-gets-180-more-days-nasdaq-meet-minimum-bid-price-until-december/) |
| 2025-06-30 | Aptevo Therapeutics [APVO](https://aibio.space/companies/aptevo-therapeutics/) | Listing change | [Aptevo says $15.9 million in new equity puts it back in line with Nasdaq rule](https://aibio.space/news/aptevo-says-15-9-million-new-equity-puts-back-line-nasdaq-rule/) |
| 2025-06-30 | IN8bio [INAB](https://aibio.space/companies/in8bio/) | Regained compliance | [IN8bio regains compliance with Nasdaq $1.00 minimum bid price rule](https://aibio.space/news/in8bio-regains-compliance-nasdaq-1-00-minimum-bid-price-rule/) |
| 2025-06-27 | Immunic [IMUX](https://aibio.space/companies/immunic/) | Deficiency notice | [Immunic gets Nasdaq notice after stock falls below $1.00 for 30 days](https://aibio.space/news/immunic-gets-nasdaq-notice-after-stock-falls-below-1-00-30-days/) |
| 2025-06-27 | Pasithea Therapeutics [KTTA](https://aibio.space/companies/pasithea-therapeutics/) | Deficiency notice | [Pasithea Therapeutics gets Nasdaq notice for trading below $1.00 bid price](https://aibio.space/news/pasithea-therapeutics-gets-nasdaq-notice-trading-below-1-00-bid-price/) |
| 2025-06-27 | Moleculin Biotech [MBRX](https://aibio.space/companies/moleculin-biotech/) | Reverse split | [Moleculin Biotech gets Nasdaq bid price notice, has until December 24, 2025](https://aibio.space/news/moleculin-biotech-gets-nasdaq-bid-price-notice-has-until-december-24/) |
| 2025-06-27 | Nektar Therapeutics [NKTR](https://aibio.space/companies/nektar-therapeutics/) | Regained compliance | [Nektar Therapeutics regains compliance with Nasdaq minimum bid price rule](https://aibio.space/news/nektar-therapeutics-regains-compliance-nasdaq-minimum-bid-price-rule/) |
| 2025-06-26 | SCYNEXIS [SCYX](https://aibio.space/companies/scynexis/) | Deficiency notice | [SCYNEXIS gets Nasdaq minimum bid price notice, has until December 17, 2025 to comply](https://aibio.space/news/scynexis-gets-nasdaq-minimum-bid-price-notice-has-until-december-17/) |
| 2025-06-26 | Bone Biologics [BBLG](https://aibio.space/companies/bone-biologics/) | Regained compliance | [Bone Biologics regains compliance with Nasdaq $1.00 minimum bid price rule](https://aibio.space/news/bone-biologics-regains-compliance-nasdaq-1-00-minimum-bid-price-rule/) |
| 2025-06-26 | Rani Therapeutics Holdings [RANI](https://aibio.space/companies/rani-therapeutics/) | Deficiency notice | [Rani Therapeutics gets Nasdaq notice over $1.00 minimum bid price](https://aibio.space/news/rani-therapeutics-gets-nasdaq-notice-1-00-minimum-bid-price/) |
| 2025-06-26 | SCYNEXIS [SCYX](https://aibio.space/companies/scynexis/) | Deficiency notice | [SCYNEXIS receives Nasdaq notice for stock below $1.00, has until December 17, 2025](https://aibio.space/news/scynexis-receives-nasdaq-notice-stock-below-1-00-has-until-december-17/) |
| 2025-06-25 | Lipella Pharmaceuticals [LIPO](https://aibio.space/companies/lipella-pharmaceuticals/) | Delisting | [Lipella Pharmaceuticals CEO says company will seek relisting after Nasdaq delisting](https://aibio.space/news/lipella-pharmaceuticals-ceo-says-company-will-seek-relisting-after/) |
| 2025-06-25 | Sutro Biopharma [STRO](https://aibio.space/companies/sutro-biopharma/) | Reverse split | [Sutro Biopharma receives Nasdaq notice for falling below $1.00 bid price](https://aibio.space/news/sutro-biopharma-receives-nasdaq-notice-falling-below-1-00-bid-price/) |
| 2025-06-23 | Caribou Biosciences [CRBU](https://aibio.space/companies/caribou-biosciences/) | Regained compliance | [Caribou Biosciences regains compliance with Nasdaq $1.00 bid price rule](https://aibio.space/news/caribou-biosciences-regains-compliance-nasdaq-1-00-bid-price-rule/) |
| 2025-06-20 | AIM ImmunoTech [AIM](https://aibio.space/companies/aim-immunotech/) | Deficiency notice | [AIM ImmunoTech gets new NYSE American notice over stockholders' deficit](https://aibio.space/news/aim-immunotech-gets-new-nyse-american-notice-stockholders-deficit/) |
| 2025-06-20 | Annovis Bio [ANVS](https://aibio.space/companies/annovis-bio/) | Deficiency notice | [NYSE accepts Annovis Bio plan to regain listing compliance](https://aibio.space/news/nyse-accepts-annovis-bio-plan-regain-listing-compliance/) |
| 2025-06-18 | C4 Therapeutics [CCCC](https://aibio.space/companies/c4-therapeutics/) | Listing change | [C4 Therapeutics holders approve doubling authorized shares to 300,000,000](https://aibio.space/news/c4-therapeutics-holders-approve-doubling-authorized-shares-300-000-000/) |
| 2025-06-18 | Vyome Holdings [HIND](https://aibio.space/companies/vyome/) | Listing change | [ReShape Lifesciences (now Vyome Holdings) says equity tops Nasdaq $2.5 million minimum](https://aibio.space/news/reshape-lifesciences-now-vyome-holdings-says-equity-tops-nasdaq-2-5/) |
| 2025-06-17 | BioNTech [BNTX](https://aibio.space/companies/biontech/) | Listing change | [BioNTech files purchase agreement to acquire CureVac through exchange offer](https://aibio.space/news/biontech-files-purchase-agreement-acquire-curevac-through-exchange/) |
| 2025-06-13 | Equillium [EQ](https://aibio.space/companies/equillium/) | Reverse split | [Equillium gets 180 more days from Nasdaq to meet minimum bid price requirement](https://aibio.space/news/equillium-gets-180-more-days-nasdaq-meet-minimum-bid-price-requirement/) |
| 2025-06-13 | Incannex Healthcare [IXHL](https://aibio.space/companies/incannex-healthcare/) | Listing change | [Incannex Healthcare applies to move its listing to the Nasdaq Capital Market](https://aibio.space/news/incannex-healthcare-applies-move-listing-nasdaq-capital-market/) |
| 2025-06-12 | AIM ImmunoTech [AIM](https://aibio.space/companies/aim-immunotech/) | Reverse split | [AIM ImmunoTech regains NYSE American compliance as 1-for-100 reverse stock split takes effect](https://aibio.space/news/aim-immunotech-regains-nyse-american-compliance-1-100-reverse-stock/) |
| 2025-06-12 | Spruce Biosciences [SPRB](https://aibio.space/companies/spruce-biosciences/) | Deficiency notice | [Spruce Biosciences wins Nasdaq panel appeal, with bid price deadline of August 5, 2025](https://aibio.space/news/spruce-biosciences-wins-nasdaq-panel-appeal-bid-price-deadline-august/) |
| 2025-06-12 | NovaBridge Biosciences [NBP](https://aibio.space/companies/novabridge-biosciences/) | Regained compliance | [I-Mab (now NovaBridge Biosciences) regains Nasdaq minimum bid price compliance](https://aibio.space/news/i-mab-now-novabridge-biosciences-regains-nasdaq-minimum-bid-price/) |
| 2025-06-12 | Spruce Biosciences [SPRB](https://aibio.space/companies/spruce-biosciences/) | Deficiency notice | [Spruce Biosciences wins Nasdaq appeal, must meet bid price rule by August 5, 2025](https://aibio.space/news/spruce-biosciences-wins-nasdaq-appeal-must-meet-bid-price-rule-august/) |
| 2025-06-06 | Bolt Biotherapeutics [BOLT](https://aibio.space/companies/bolt-biotherapeutics/) | Reverse split | [Bolt Biotherapeutics sets 1-for-20 reverse stock split, trading adjusted June 9](https://aibio.space/news/bolt-biotherapeutics-sets-1-20-reverse-stock-split-trading-adjusted/) |
| 2025-06-06 | Bolt Biotherapeutics [BOLT](https://aibio.space/companies/bolt-biotherapeutics/) | Reverse split | [Bolt Biotherapeutics effects 1:20 reverse stock split](https://aibio.space/news/bolt-biotherapeutics-effects-1-20-reverse-stock-split/) |
| 2025-06-06 | Tango Therapeutics [TNGX](https://aibio.space/companies/tango-therapeutics/) | Listing change | [Tango Therapeutics holders approve doubling authorized shares to 400,000,000](https://aibio.space/news/tango-therapeutics-holders-approve-doubling-authorized-shares-400-000/) |
| 2025-06-05 | Talphera [TLPH](https://aibio.space/companies/talphera/) | Reverse split | [Talphera gets second 180-day Nasdaq bid price period, to December 1, 2025](https://aibio.space/news/talphera-gets-second-180-day-nasdaq-bid-price-period-december-1-2025/) |
| 2025-06-05 | Talphera [TLPH](https://aibio.space/companies/talphera/) | Reverse split | [Talphera gets second 180-day Nasdaq period, until December 1, 2025, to fix bid price](https://aibio.space/news/talphera-gets-second-180-day-nasdaq-period-until-december-1-2025-fix/) |
| 2025-06-04 | Nektar Therapeutics [NKTR](https://aibio.space/companies/nektar-therapeutics/) | Reverse split | [Nektar sets one-for-fifteen reverse split, effective June 8, 2025](https://aibio.space/news/nektar-sets-one-fifteen-reverse-split-effective-june-8-2025/) |
| 2025-06-03 | Ironwood Pharmaceuticals [IRWD](https://aibio.space/companies/ironwood-pharmaceuticals/) | Deficiency notice | [Ironwood Pharmaceuticals gets Nasdaq minimum bid price deficiency notice](https://aibio.space/news/ironwood-pharmaceuticals-gets-nasdaq-minimum-bid-price-deficiency/) |
| 2025-06-03 | Taysha Gene Therapies [TSHA](https://aibio.space/companies/taysha-gene-therapies/) | Listing change | [Taysha Gene Therapies holders approve raising authorized shares to 700,000,000](https://aibio.space/news/taysha-gene-therapies-holders-approve-raising-authorized-shares-700/) |
| 2025-06-02 | Editas Medicine [EDIT](https://aibio.space/companies/editas-medicine/) | Listing change | [Editas Medicine holders approve doubling authorized common stock to 390,000,000](https://aibio.space/news/editas-medicine-holders-approve-doubling-authorized-common-stock-390/) |
| 2025-05-30 | Vyome Holdings [HIND](https://aibio.space/companies/vyome/) | Delisting | [ReShape Lifesciences (now Vyome Holdings) sets up $9,700,000 at-the-market program](https://aibio.space/news/reshape-lifesciences-now-vyome-holdings-sets-up-9-700-000-market/) |
| 2025-05-30 | MetaVia [MTVA](https://aibio.space/companies/metavia/) | Deficiency notice | [MetaVia gets Nasdaq minimum bid price notice, deadline November 25, 2025](https://aibio.space/news/metavia-gets-nasdaq-minimum-bid-price-notice-deadline-november-25-2025/) |
| 2025-05-28 | CytomX Therapeutics [CTMX](https://aibio.space/companies/cytomx-therapeutics/) | Regained compliance | [CytomX Therapeutics regains compliance with Nasdaq minimum bid price requirement](https://aibio.space/news/cytomx-therapeutics-regains-compliance-nasdaq-minimum-bid-price/) |
| 2025-05-27 | Definium Therapeutics [DFTX](https://aibio.space/companies/definium-therapeutics/) | Listing change | [Mind Medicine (now Definium Therapeutics) grants new CFO inducement awards](https://aibio.space/news/mind-medicine-now-definium-therapeutics-grants-new-cfo-inducement/) |
| 2025-05-23 | Artelo Biosciences [ARTL](https://aibio.space/companies/artelo-biosciences/) | Deficiency notice | [Artelo Biosciences gets Nasdaq notice for $652,000 stockholders' equity, below $2,500,000 minimum](https://aibio.space/news/artelo-biosciences-gets-nasdaq-notice-652-000-stockholders-equity/) |
| 2025-05-23 | Cerenome [CNSY](https://aibio.space/companies/cerenome/) | Deficiency notice | [Plus Therapeutics (now Cerenome) gets Nasdaq deficiency notice over late Form 10-Q](https://aibio.space/news/plus-therapeutics-now-cerenome-gets-nasdaq-deficiency-notice-late-form/) |
| 2025-05-23 | Biofrontera [BFRI](https://aibio.space/companies/biofrontera-bfri/) | Listing change | [Biofrontera falls below Nasdaq $2,500,000 stockholders' equity requirement](https://aibio.space/news/biofrontera-falls-below-nasdaq-2-500-000-stockholders-equity/) |
| 2025-05-23 | Q32 Bio [QTTB](https://aibio.space/companies/q32-bio/) | Deficiency notice | [Q32 Bio gets Nasdaq notice after reporting stockholders' deficit of ($4.0 million)](https://aibio.space/news/q32-bio-gets-nasdaq-notice-after-reporting-stockholders-deficit-4-0/) |
| 2025-05-22 | Oncopeptides AB [ONCO](https://aibio.space/companies/oncopeptides/) | Delisting | [Onconetix gets Nasdaq notice for unfiled 10-Q, issues $294,117.65 note to Keystone](https://aibio.space/news/onconetix-gets-nasdaq-notice-unfiled-10-q-issues-294-117-65-note/) |
| 2025-05-22 | Aptevo Therapeutics [APVO](https://aibio.space/companies/aptevo-therapeutics/) | Reverse split | [Aptevo Therapeutics gets Nasdaq stockholders' equity notice, sets 1-for-20 reverse stock split](https://aibio.space/news/aptevo-therapeutics-gets-nasdaq-stockholders-equity-notice-sets-1-20/) |
| 2025-05-22 | Sol-Gel Technologies [SLGL](https://aibio.space/companies/sol-gel-technologies/) | Regained compliance | [Sol-Gel Technologies regains Nasdaq minimum bid price compliance after extension](https://aibio.space/news/sol-gel-technologies-regains-nasdaq-minimum-bid-price-compliance-after/) |
| 2025-05-21 | Petros Pharmaceuticals [PTPI](https://aibio.space/companies/petros-pharmaceuticals/) | Delisting | [Nasdaq panel moves to delist Petros Pharmaceuticals, trading to shift to OTC](https://aibio.space/news/nasdaq-panel-moves-delist-petros-pharmaceuticals-trading-shift-otc/) |
| 2025-05-20 | Intensity Therapeutics [INTS](https://aibio.space/companies/intensity-therapeutics/) | Deficiency notice | [Intensity Therapeutics gets Nasdaq stockholders' equity deficiency notice](https://aibio.space/news/intensity-therapeutics-gets-nasdaq-stockholders-equity-deficiency/) |
| 2025-05-16 | Dermata Therapeutics [DRMA](https://aibio.space/companies/dermata-therapeutics/) | Regained compliance | [Dermata regains Nasdaq stockholders' equity compliance but gets bid price delisting notice](https://aibio.space/news/dermata-regains-nasdaq-stockholders-equity-compliance-but-gets-bid/) |
| 2025-05-16 | Neumora Therapeutics [NMRA](https://aibio.space/companies/neumora-therapeutics/) | Reverse split | [Neumora gets Nasdaq minimum bid price notice, has until November 10, 2025 to comply](https://aibio.space/news/neumora-gets-nasdaq-minimum-bid-price-notice-has-until-november-10/) |
| 2025-05-16 | Neumora Therapeutics [NMRA](https://aibio.space/companies/neumora-therapeutics/) | Reverse split | [Neumora Therapeutics gets Nasdaq notice for stock below $1.00 bid price](https://aibio.space/news/neumora-therapeutics-gets-nasdaq-notice-stock-below-1-00-bid-price/) |
| 2025-05-15 | Vyome Holdings [HIND](https://aibio.space/companies/vyome/) | Reverse split | [ReShape Lifesciences (now Vyome Holdings) files NT 10-Q, delaying its first-quarter 10-Q](https://aibio.space/news/reshape-lifesciences-now-vyome-holdings-files-nt-10-q-delaying-first/) |
| 2025-05-15 | Vyome Holdings [HIND](https://aibio.space/companies/vyome/) | Reverse split | [ReShape Lifesciences (now Vyome Holdings) delays first-quarter 10-Q](https://aibio.space/news/reshape-lifesciences-now-vyome-holdings-delays-first-quarter-10/) |
| 2025-05-15 | Valion Bio [VBIO](https://aibio.space/companies/valion-bio/) | Listing change | [Tivic Health (now Valion Bio) ends quarter with $669,000 cash, lines up financing](https://aibio.space/news/tivic-health-now-valion-bio-ends-quarter-669-000-cash-lines-up/) |
| 2025-05-13 | Sangamo Therapeutics [SGMOQ](https://aibio.space/companies/sangamo-therapeutics/) | Listing change | [Sangamo Therapeutics prices $23.0 million offering of stock and warrants at $0.50](https://aibio.space/news/sangamo-therapeutics-prices-23-0-million-offering-stock-warrants-0-50/) |
| 2025-05-12 | Hepion Pharmaceuticals [HEPA](https://aibio.space/companies/hepion-pharmaceuticals/) | Delisting | [Nasdaq panel delists Hepion Pharmaceuticals; company expects OTC quotation](https://aibio.space/news/nasdaq-panel-delists-hepion-pharmaceuticals-company-expects-otc/) |
| 2025-05-12 | Immunome [IMNM](https://aibio.space/companies/immunome/) | Listing change | [Immunome reports $317.3 million in cash and expects runway into 2027](https://aibio.space/news/immunome-reports-317-3-million-cash-expects-runway-2027/) |
| 2025-05-07 | Cosmos Health [COSM](https://aibio.space/companies/cosmos-health/) | Listing change | [Cosmos Health gets second 180-day Nasdaq period to lift stock above $1.00](https://aibio.space/news/cosmos-health-gets-second-180-day-nasdaq-period-lift-stock-above-1-00/) |
| 2025-05-07 | TransCode Therapeutics [RNAZ](https://aibio.space/companies/transcode-therapeutics/) | Reverse split | [TransCode Therapeutics faces Nasdaq delisting with no grace period, plans hearing](https://aibio.space/news/transcode-therapeutics-faces-nasdaq-delisting-no-grace-period-plans/) |
| 2025-05-02 | Palisade Bio [PALI](https://aibio.space/companies/palisade-bio/) | Deficiency notice | [Palisade Bio gets Nasdaq minimum bid price deficiency notice, has 180 days to regain compliance](https://aibio.space/news/palisade-bio-gets-nasdaq-minimum-bid-price-deficiency-notice-has-180/) |
| 2025-05-02 | Palisade Bio [PALI](https://aibio.space/companies/palisade-bio/) | Deficiency notice | [Palisade Bio gets Nasdaq notice for trading below $1.00 minimum bid price](https://aibio.space/news/palisade-bio-gets-nasdaq-notice-trading-below-1-00-minimum-bid-price/) |
| 2025-05-01 | Armata Pharmaceuticals [ARMP](https://aibio.space/companies/armata-pharmaceuticals/) | Listing change | [Armata Pharmaceuticals flags going concern paragraph, gets $4.65 million from DoD](https://aibio.space/news/armata-pharmaceuticals-flags-going-concern-paragraph-gets-4-65-million/) |
| 2025-04-30 | ABVC BioPharma [ABVC](https://aibio.space/companies/abvc-biopharma/) | Deficiency notice | [ABVC BioPharma gets Nasdaq equity notice and sells 724,372 shares offshore](https://aibio.space/news/abvc-biopharma-gets-nasdaq-equity-notice-sells-724-372-shares-offshore/) |
| 2025-04-30 | Quoin Pharmaceuticals [QNRX](https://aibio.space/companies/quoin-pharmaceuticals/) | Regained compliance | [Quoin Pharmaceuticals regains compliance with Nasdaq $1.00 minimum bid price rule](https://aibio.space/news/quoin-pharmaceuticals-regains-compliance-nasdaq-1-00-minimum-bid-price/) |
| 2025-04-30 | Scilex Holding [SCLX](https://aibio.space/companies/scilex/) | Regained compliance | [Scilex Holding regains compliance with Nasdaq minimum bid price rule](https://aibio.space/news/scilex-holding-regains-compliance-nasdaq-minimum-bid-price-rule/) |
| 2025-04-30 | XTL Biopharmaceuticals [XTLB](https://aibio.space/companies/xtl-biopharmaceuticals/) | Delisting | [XTL Biopharmaceuticals 20-F lists going-concern and delisting risks](https://aibio.space/news/xtl-biopharmaceuticals-20-f-lists-going-concern-delisting-risks/) |
| 2025-04-29 | Amarin Corporation [AMRN](https://aibio.space/companies/amarin/) | Regained compliance | [Amarin regains compliance with Nasdaq minimum bid price requirement](https://aibio.space/news/amarin-regains-compliance-nasdaq-minimum-bid-price-requirement/) |
| 2025-04-28 | Tempest Therapeutics [TPST](https://aibio.space/companies/tempest-therapeutics/) | Regained compliance | [Tempest Therapeutics regains compliance with Nasdaq $1.00 bid price rule](https://aibio.space/news/tempest-therapeutics-regains-compliance-nasdaq-1-00-bid-price-rule/) |
| 2025-04-25 | Decoy Therapeutics [DCOY](https://aibio.space/companies/decoy-therapeutics/) | Reverse split | [Salarius Pharmaceuticals (now Decoy Therapeutics) gets Nasdaq delisting notice, plans appeal](https://aibio.space/news/salarius-pharmaceuticals-now-decoy-therapeutics-gets-nasdaq-delisting/) |
| 2025-04-25 | Incannex Healthcare [IXHL](https://aibio.space/companies/incannex-healthcare/) | Deficiency notice | [Incannex Healthcare Inc. gets Nasdaq minimum bid price notice, has until October 20, 2025](https://aibio.space/news/incannex-healthcare-inc-gets-nasdaq-minimum-bid-price-notice-has-until/) |
| 2025-04-25 | Spruce Biosciences [SPRB](https://aibio.space/companies/spruce-biosciences/) | Delisting | [Spruce Biosciences gets Nasdaq delisting notice, suspension set for April 29, cuts staff 55%](https://aibio.space/news/spruce-biosciences-gets-nasdaq-delisting-notice-suspension-set-april/) |
| 2025-04-25 | AEON Biopharma [AEON](https://aibio.space/companies/aeon-biopharma/) | Listing change | [NYSE American accepts AEON Biopharma plan, sets August 3, 2026 deadline](https://aibio.space/news/nyse-american-accepts-aeon-biopharma-plan-sets-august-3-2026-deadline/) |
| 2025-04-18 | Aspire-Lakewood Holdings [ASBP](https://aibio.space/companies/aspire-lakewood/) | Deficiency notice | [Aspire Biopharma (now Aspire-Lakewood Holdings) gets two Nasdaq deficiency letters](https://aibio.space/news/aspire-biopharma-now-aspire-lakewood-holdings-gets-two-nasdaq/) |
| 2025-04-18 | Tenaya Therapeutics [TNYA](https://aibio.space/companies/tenaya-therapeutics/) | Deficiency notice | [Tenaya Therapeutics gets Nasdaq notice for trading below $1.00](https://aibio.space/news/tenaya-therapeutics-gets-nasdaq-notice-trading-below-1-00/) |
| 2025-04-17 | PRF Technologies [PRFX](https://aibio.space/companies/prf-technologies/) | Delisting | [PainReform (now PRF Technologies) says Nasdaq found it compliant with Rule 5550(b)(1)](https://aibio.space/news/painreform-now-prf-technologies-says-nasdaq-found-compliant-rule-5550/) |
| 2025-04-16 | Aspira Women's Health [AWHL](https://aibio.space/companies/aspira-women-s-health/) | Delisting | [Nasdaq panel delists Aspira Women's Health over $2.5 million equity rule](https://aibio.space/news/nasdaq-panel-delists-aspira-womens-health-2-5-million-equity-rule/) |
| 2025-04-16 | LeonaBio [LONA](https://aibio.space/companies/leonabio/) | Reverse split | [Athira Pharma (now LeonaBio) wins Nasdaq Capital Market move and 180 more days](https://aibio.space/news/athira-pharma-now-leonabio-wins-nasdaq-capital-market-move-180-more/) |
| 2025-04-15 | Tvardi Therapeutics [TVRD](https://aibio.space/companies/tvardi-therapeutics/) | Reverse split | [Cara Therapeutics (now Tvardi Therapeutics) closes merger with Tvardi, 1-for-3 reverse split](https://aibio.space/news/cara-therapeutics-now-tvardi-therapeutics-closes-merger-tvardi-1-3/) |
| 2025-04-11 | MIRA Pharmaceuticals [MIRA](https://aibio.space/companies/mira-pharmaceuticals/) | Deficiency notice | [MIRA Pharmaceuticals gets Nasdaq notice on $2.5 million stockholders' equity requirement](https://aibio.space/news/mira-pharmaceuticals-gets-nasdaq-notice-2-5-million-stockholders/) |
| 2025-04-11 | Creative Medical Technology Holdings [CELZ](https://aibio.space/companies/creative-medical-technology/) | Listing change | [Nasdaq closes Creative Medical Technology clawback policy compliance matter](https://aibio.space/news/nasdaq-closes-creative-medical-technology-clawback-policy-compliance/) |
| 2025-04-11 | MIRA Pharmaceuticals [MIRA](https://aibio.space/companies/mira-pharmaceuticals/) | Deficiency notice | [MIRA Pharmaceuticals gets Nasdaq notice over $2.5 million equity rule](https://aibio.space/news/mira-pharmaceuticals-gets-nasdaq-notice-2-5-million-equity-rule/) |
| 2025-04-10 | Palatin Technologies [PTN](https://aibio.space/companies/palatin-technologies/) | Delisting | [Palatin Technologies gets NYSE American delisting notice, plans to appeal](https://aibio.space/news/palatin-technologies-gets-nyse-american-delisting-notice-plans-appeal/) |
| 2025-04-09 | Amarin Corporation [AMRN](https://aibio.space/companies/amarin/) | Listing change | [Amarin sets 1-for-20 ADS ratio change for April 11 to keep Nasdaq listing](https://aibio.space/news/amarin-sets-1-20-ads-ratio-change-april-11-keep-nasdaq-listing/) |
| 2025-04-09 | Semnur Pharmaceuticals [SMNR](https://aibio.space/companies/semnur-pharmaceuticals/) | Delisting | [Nasdaq moves to delist Denali Capital (now Semnur Pharmaceuticals), the Semnur SPAC](https://aibio.space/news/nasdaq-moves-delist-denali-capital-now-semnur-pharmaceuticals-semnur/) |
| 2025-04-07 | AIM ImmunoTech [AIM](https://aibio.space/companies/aim-immunotech/) | Delisting | [AIM ImmunoTech gets NYSE American delisting notice over low stock price](https://aibio.space/news/aim-immunotech-gets-nyse-american-delisting-notice-low-stock-price/) |
| 2025-04-07 | XBiotech [XBIT](https://aibio.space/companies/xbiotech/) | Listing change | [XBiotech tells Nasdaq of audit committee vacancy after director retires](https://aibio.space/news/xbiotech-tells-nasdaq-audit-committee-vacancy-after-director-retires/) |
| 2025-04-03 | Dogwood Therapeutics [DWTX](https://aibio.space/companies/dogwood-therapeutics/) | Listing change | [Dogwood Therapeutics says it has regained Nasdaq stockholders' equity compliance](https://aibio.space/news/dogwood-therapeutics-says-has-regained-nasdaq-stockholders-equity/) |
| 2025-04-01 | Tvardi Therapeutics [TVRD](https://aibio.space/companies/tvardi-therapeutics/) | Reverse split | [Cara Therapeutics (now Tvardi Therapeutics) stockholders approve Tvardi merger share issuance](https://aibio.space/news/cara-therapeutics-now-tvardi-therapeutics-stockholders-approve-tvardi/) |
| 2025-04-01 | CDT Equity [CDT](https://aibio.space/companies/cdt-equity/) | Listing change | [Conduit Pharmaceuticals (now CDT Equity) says it meets Nasdaq equity standard](https://aibio.space/news/conduit-pharmaceuticals-now-cdt-equity-says-meets-nasdaq-equity/) |
| 2025-03-31 | CNS Pharmaceuticals [CNSP](https://aibio.space/companies/cns-pharmaceuticals/) | Regained compliance | [CNS Pharmaceuticals regains Nasdaq bid price compliance, faces one-year monitor](https://aibio.space/news/cns-pharmaceuticals-regains-nasdaq-bid-price-compliance-faces-one-year/) |
| 2025-03-28 | Acurx Pharmaceuticals [ACXP](https://aibio.space/companies/acurx-pharmaceuticals/) | Deficiency notice | [Acurx Pharmaceuticals gets Nasdaq stockholders' equity deficiency notice](https://aibio.space/news/acurx-pharmaceuticals-gets-nasdaq-stockholders-equity-deficiency/) |
| 2025-03-27 | Annovis Bio [ANVS](https://aibio.space/companies/annovis-bio/) | Deficiency notice | [Annovis Bio gets NYSE continued listing notice, will submit compliance plan within 45 days](https://aibio.space/news/annovis-bio-gets-nyse-continued-listing-notice-will-submit-compliance/) |
| 2025-03-27 | Ironwood Pharmaceuticals [IRWD](https://aibio.space/companies/ironwood-pharmaceuticals/) | Deficiency notice | [Ironwood Pharmaceuticals gets Nasdaq deficiency notice over late 2024 Form 10-K](https://aibio.space/news/ironwood-pharmaceuticals-gets-nasdaq-deficiency-notice-late-2024-form/) |
| 2025-03-25 | Dermata Therapeutics [DRMA](https://aibio.space/companies/dermata-therapeutics/) | Deficiency notice | [Dermata Therapeutics gets Nasdaq stockholders' equity deficiency notice, has until May 9, 2025](https://aibio.space/news/dermata-therapeutics-gets-nasdaq-stockholders-equity-deficiency-notice/) |
| 2025-03-25 | Jupiter Neurosciences [JUNS](https://aibio.space/companies/jupiter-neurosciences/) | Deficiency notice | [Jupiter Neurosciences gets Nasdaq minimum bid price deficiency notice](https://aibio.space/news/jupiter-neurosciences-gets-nasdaq-minimum-bid-price-deficiency-notice/) |
| 2025-03-21 | Q/C Technologies [QCLS](https://aibio.space/companies/q-c-technologies/) | Deficiency notice | [TNF Pharmaceuticals (now Q/C Technologies) gets Nasdaq minimum bid price notice](https://aibio.space/news/tnf-pharmaceuticals-now-q-c-technologies-gets-nasdaq-minimum-bid/) |
| 2025-03-21 | Q/C Technologies [QCLS](https://aibio.space/companies/q-c-technologies/) | Deficiency notice | [TNF Pharmaceuticals (now Q/C Technologies) gets Nasdaq minimum bid notice](https://aibio.space/news/tnf-pharmaceuticals-now-q-c-technologies-gets-nasdaq-minimum-bid/) |
| 2025-03-19 | Minerva Neurosciences [NERV](https://aibio.space/companies/minerva-neurosciences/) | Deficiency notice | [Minerva Neurosciences keeps Nasdaq listing after meeting $500,000 net income rule](https://aibio.space/news/minerva-neurosciences-keeps-nasdaq-listing-after-meeting-500-000-net/) |
| 2025-03-17 | Kyntra Bio [KYNB](https://aibio.space/companies/kyntra-bio/) | Delisting | [FibroGen (now Kyntra Bio) appeals Nasdaq delisting notice after missing minimum bid price deadline](https://aibio.space/news/fibrogen-now-kyntra-bio-appeals-nasdaq-delisting-notice-after-missing/) |
| 2025-03-17 | Avenue Therapeutics [ATXI](https://aibio.space/companies/avenue-therapeutics/) | Delisting | [Nasdaq panel delists Avenue Therapeutics; stock moves to OTC on March 19, 2025](https://aibio.space/news/nasdaq-panel-delists-avenue-therapeutics-stock-moves-otc-march-19-2025/) |
| 2025-03-17 | Vaccinex [VCNX](https://aibio.space/companies/vaccinex/) | Delisting | [Vaccinex files Form 25 to voluntarily withdraw its stock from Nasdaq](https://aibio.space/news/vaccinex-files-form-25-voluntarily-withdraw-stock-nasdaq/) |
| 2025-03-14 | Gelteq [GELS](https://aibio.space/companies/gelteq/) | Listing change | [Gelteq signs deal to sell up to $12,000,000 of shares to Lincoln Park](https://aibio.space/news/gelteq-signs-deal-sell-up-12-000-000-shares-lincoln-park/) |
| 2025-03-14 | Tiziana Life Sciences [TLSA](https://aibio.space/companies/tiziana-life-sciences/) | Regained compliance | [Tiziana Life Sciences regains compliance with Nasdaq minimum bid price rule](https://aibio.space/news/tiziana-life-sciences-regains-compliance-nasdaq-minimum-bid-price-rule/) |
| 2025-03-13 | Shuttle Pharmaceuticals Holdings [SHPH](https://aibio.space/companies/shuttle-pharmaceuticals/) | Listing change | [Shuttle Pharma prices $5.75 million underwritten offering at $0.30 per share](https://aibio.space/news/shuttle-pharma-prices-5-75-million-underwritten-offering-0-30-share/) |
| 2025-03-07 | Adial Pharmaceuticals [ADIL](https://aibio.space/companies/adial-pharmaceuticals/) | Deficiency notice | [Adial Pharmaceuticals gets Nasdaq minimum bid price deficiency notice, has until September 1, 2025](https://aibio.space/news/adial-pharmaceuticals-gets-nasdaq-minimum-bid-price-deficiency-notice/) |
| 2025-03-03 | Envoy Medical [COCH](https://aibio.space/companies/envoy-medical/) | Deficiency notice | [Envoy Medical receives Nasdaq deficiency notice on $35,000,000 market value requirement](https://aibio.space/news/envoy-medical-receives-nasdaq-deficiency-notice-35-000-000-market/) |
| 2025-03-03 | iBio [IBIO](https://aibio.space/companies/ibio/) | Delisting | [iBio files Form 25 to withdraw its common stock from NYSE American](https://aibio.space/news/ibio-files-form-25-withdraw-common-stock-nyse-american/) |
| 2025-02-27 | Curis [CRIS](https://aibio.space/companies/curis/) | Deficiency notice | [Curis gets Nasdaq deficiency notice on market value of listed securities](https://aibio.space/news/curis-gets-nasdaq-deficiency-notice-market-value-listed-securities/) |
| 2025-02-26 | CytomX Therapeutics [CTMX](https://aibio.space/companies/cytomx-therapeutics/) | Deficiency notice | [CytomX Therapeutics gets Nasdaq minimum bid price deficiency notice, has until August 25, 2025](https://aibio.space/news/cytomx-therapeutics-gets-nasdaq-minimum-bid-price-deficiency-notice/) |
| 2025-02-25 | Rallybio [RLYB](https://aibio.space/companies/rallybio/) | Deficiency notice | [Rallybio gets Nasdaq minimum bid price notice, has until August 25, 2025](https://aibio.space/news/rallybio-gets-nasdaq-minimum-bid-price-notice-has-until-august-25-2025/) |
| 2025-02-25 | Universe Pharmaceuticals [UPC](https://aibio.space/companies/universe-pharmaceuticals/) | Delisting | [Universe Pharmaceuticals gets Nasdaq delisting notice over delayed Form 20-F](https://aibio.space/news/universe-pharmaceuticals-gets-nasdaq-delisting-notice-delayed-form-20/) |
| 2025-02-24 | Atossa Therapeutics [ATOS](https://aibio.space/companies/atossa-therapeutics/) | Deficiency notice | [Atossa Therapeutics gets Nasdaq minimum bid price deficiency notice, has until August 20, 2025](https://aibio.space/news/atossa-therapeutics-gets-nasdaq-minimum-bid-price-deficiency-notice/) |
| 2025-02-20 | Pharming Group NV, Egyptian International Pharmaceutical Industries Co. [PHARM](https://aibio.space/companies/pharming/)[PHAR](https://aibio.space/companies/egyptian-international-pharmaceutical-industries/) | Delisting | [Pharming lifts its stake in Abliva to 92.70 percent and extends cash offer to March 6](https://aibio.space/news/pharming-lifts-stake-abliva-92-70-percent-extends-cash-offer-march-6/) |
| 2025-02-19 | CDT Equity [CDT](https://aibio.space/companies/cdt-equity/) | Delisting | [Conduit Pharmaceuticals (now CDT Equity) repays Nirland note as Nasdaq cites more delisting grounds](https://aibio.space/news/conduit-pharmaceuticals-now-cdt-equity-repays-nirland-note-nasdaq/) |
| 2025-02-14 | Citius Pharmaceuticals, Citius Oncology [CTXR](https://aibio.space/companies/citius-pharmaceuticals/)[CTOR](https://aibio.space/companies/citius-oncology/) | Listing change | [Citius Pharmaceuticals reports $1.1 million cash and expects to raise capital](https://aibio.space/news/citius-pharmaceuticals-reports-1-1-million-cash-expects-raise-capital/) |
| 2025-02-14 | Evaxion [EVAX](https://aibio.space/companies/evaxion/) | Delisting | [Nasdaq withdraws Evaxion Biotech (now Evaxion A/S) delisting determination](https://aibio.space/news/nasdaq-withdraws-evaxion-biotech-now-evaxion-s-delisting-determination/) |
| 2025-02-13 | Ovid Therapeutics [OVID](https://aibio.space/companies/ovid-therapeutics/) | Deficiency notice | [Ovid Therapeutics gets Nasdaq minimum bid price notice, has until August 11, 2025](https://aibio.space/news/ovid-therapeutics-gets-nasdaq-minimum-bid-price-notice-has-until/) |
| 2025-02-13 | BriaCell Therapeutics, BriaCell Therapeutics [BCT](https://aibio.space/companies/briacell-therapeutics/)[BCTX](https://aibio.space/companies/briacell-therapeutics-bctx/) | Regained compliance | [BriaCell Therapeutics regains compliance with Nasdaq minimum bid price requirement](https://aibio.space/news/briacell-therapeutics-regains-compliance-nasdaq-minimum-bid-price/) |
| 2025-02-12 | Genprex [GNPX](https://aibio.space/companies/genprex/) | Deficiency notice | [Genprex gets Nasdaq minimum bid price deficiency notice, has until August 6, 2025](https://aibio.space/news/genprex-gets-nasdaq-minimum-bid-price-deficiency-notice-has-until/) |
| 2025-02-07 | Mustang Bio, Fortress Biotech [MBIO](https://aibio.space/companies/mustang-bio/)[FBIO](https://aibio.space/companies/fortress-biotech/) | Reverse split | [Mustang Bio prices $8 million offering at $3.01 with two series of warrants](https://aibio.space/news/mustang-bio-prices-8-million-offering-3-01-two-series-warrants/) |
| 2025-01-27 | China SXT Pharmaceuticals [SXTC](https://aibio.space/companies/china-sxt-pharmaceuticals/) | Listing change | [China SXT Pharmaceuticals files securities purchase agreement priced at $0.20 per share](https://aibio.space/news/china-sxt-pharmaceuticals-files-securities-purchase-agreement-priced-0/) |
| 2025-01-21 | Pluri [PLUR](https://aibio.space/companies/pluri/) | Delisting | [Pluri gets Nasdaq extension to May 24, 2025 to regain stockholders' equity compliance](https://aibio.space/news/pluri-gets-nasdaq-extension-may-24-2025-regain-stockholders-equity/) |
| 2025-01-17 | PolyPid [PYPD](https://aibio.space/companies/polypid/) | Delisting | [PolyPid says $14.5 million private placement restored Nasdaq equity compliance](https://aibio.space/news/polypid-says-14-5-million-private-placement-restored-nasdaq-equity/) |
| 2025-01-15 | Gain Therapeutics [GANX](https://aibio.space/companies/gain-therapeutics/) | Regained compliance | [Gain Therapeutics regains compliance with Nasdaq $50 million market value requirement](https://aibio.space/news/gain-therapeutics-regains-compliance-nasdaq-50-million-market-value/) |
| 2025-01-14 | Evaxion [EVAX](https://aibio.space/companies/evaxion/) | Listing change | [Evaxion Biotech (now Evaxion A/S) completes ADS ratio change, like a 1-for-5 split](https://aibio.space/news/evaxion-biotech-now-evaxion-s-completes-ads-ratio-change-like-1-5/) |
| 2025-01-10 | Matinas Biopharma Holdings [MTNB](https://aibio.space/companies/matinas-biopharma/) | Deficiency notice | [Matinas BioPharma gets NYSE American deficiency notice for missing 2024 annual meeting](https://aibio.space/news/matinas-biopharma-gets-nyse-american-deficiency-notice-missing-2024/) |
| 2025-01-10 | Incannex Healthcare [IXHL](https://aibio.space/companies/incannex-healthcare/) | Deficiency notice | [Incannex gets Nasdaq deficiency notice on $50.0 million market value requirement](https://aibio.space/news/incannex-gets-nasdaq-deficiency-notice-50-0-million-market-value/) |
| 2025-01-07 | Faeth Therapeutics [FTH](https://aibio.space/companies/faeth-therapeutics/) | Listing change | [Sensei Biotherapeutics, Inc. (now Faeth Therapeutics, Inc.) gets 180 more days to meet Nasdaq bid price rule](https://aibio.space/news/sensei-biotherapeutics-inc-now-faeth-therapeutics-inc-gets-180-more/) |
| 2025-01-07 | Revelation Biosciences [REVB](https://aibio.space/companies/revelation-biosciences/) | Reverse split | [Nasdaq panel keeps Revelation Biosciences listed on condition of reverse stock split](https://aibio.space/news/nasdaq-panel-keeps-revelation-biosciences-listed-condition-reverse/) |
| 2025-01-03 | Ocugen [OCGN](https://aibio.space/companies/ocugen/) | Deficiency notice | [Ocugen gets Nasdaq minimum bid price deficiency notice, has until June 30, 2025](https://aibio.space/news/ocugen-gets-nasdaq-minimum-bid-price-deficiency-notice-has-until-june/) |
| 2024-12-31 | Psyence Biomedical [PBM](https://aibio.space/companies/psyence-biomedical/) | Listing change | [Psyence Biomedical agrees to $2.0 million private placement with warrants](https://aibio.space/news/psyence-biomedical-agrees-2-0-million-private-placement-warrants/) |
| 2024-12-26 | Regen Biopharma [RGBP](https://aibio.space/companies/regen-biopharma/) | Delisting | [Regen Biopharma files Form 15 for common and Series A preferred stock](https://aibio.space/news/regen-biopharma-files-form-15-common-series-preferred-stock/) |
| 2024-12-20 | Altamira Therapeutics [CYTOF](https://aibio.space/companies/altamira-therapeutics/) | Reverse split | [Altamira Therapeutics moves from Nasdaq to OTCQB after panel decision](https://aibio.space/news/altamira-therapeutics-moves-nasdaq-otcqb-after-panel-decision/) |
| 2024-12-12 | Neutra [NTRR](https://aibio.space/companies/neutra/) | Delisting | [Neutra Corp. files Form 15 to end SEC reporting duties](https://aibio.space/news/neutra-corp-files-form-15-end-sec-reporting-duties/) |
| 2024-10-28 | Calidi Biotherapeutics [CLDI](https://aibio.space/companies/calidi-biotherapeutics/) | Deficiency notice | [NYSE American files to remove Calidi Biotherapeutics warrants from listing](https://aibio.space/news/nyse-american-files-remove-calidi-biotherapeutics-warrants-listing/) |

## How this tracker works

We add an event when the company files it with the SEC (usually a Form 8-K, Item 3.01 for exchange notices) or the exchange publishes it. The split ratio and dates are as stated in the filing. Every row links our story, and every story links the filing, court record or release it is based on. Something missing or wrong? [Tell the editors](https://aibio.space/reputation/#correction).

News, not investment advice. [How we work](https://aibio.space/disclosures/).

---
Source page: https://aibio.space/reverse-split-tracker/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Biotech reverse split, Nasdaq notice and delisting tracker", 2026-10-31, https://aibio.space/reverse-split-tracker/